Ask OpenScientist

Ask a research question about ARX-Related Lissencephaly and Interneuronopathy. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
7
Pathophys.
8
Phenotypes
1
Gaps
16
Pathograph
1
Genes
3
Medical Actions
8
References
1
Deep Research
👪

Inheritance

1
X-linked inheritance HP:0001417
X-linked inheritance
Show evidence (1 reference)
PMID:12379852 SUPPORT Human Clinical
"The present report is, to our knowledge, the first to use phenotypic analysis of a knockout mouse to identify a gene associated with an X-linked human brain malformation."
The founding ARX/XLAG report identifies ARX as the gene for an X-linked human brain malformation.
?

Discussions and Knowledge Gaps

1
Does the Arx-null mouse — the founding and principal animal model of ARX-related disease — faithfully recapitulate the defining human XLAG cortical malformation, or does the fact that the mouse is a natively lissencephalic (agyric) species, lacking the expanded outer subventricular zone (OSVZ) and outer radial glia (oRG) that drive gyrencephalic cortical surface expansion in humans, mean that the model robustly reproduces the subpallial interneuronopathy, tangential-migration, basal-ganglia and genital arms but cannot phenocopy the anterior-pachygyria/posterior-agyria "lissencephaly" that gives XLAG its name?
HUMAN MODEL MISMATCH OPEN gap_arx_mouse_lissencephaly_gyrencephaly_mismatch
The Arx-null mouse establishes the causal logic of this entry: it reproduces the disrupted subpallial patterning, the impaired tangential and radial migration of ganglionic-eminence-derived GABAergic interneurons, the basal-ganglia/thalamocortical wiring defects, the abnormal testicular differentiation, and the developmental epilepsy — i.e., the interneuronopathy skeleton that this entry conforms to. However, the founding report itself is careful to state that the mouse recapitulates only *some* of the human features, and the cardinal human XLAG neuroradiological lesion — a mildly thickened agyric/pachygyric cortex (lissencephaly) — is precisely the arm the rodent cannot phenocopy, because a baseline-agyric mouse cortex has no gyral architecture to lose and lacks the human-enriched OSVZ/oRG amplification tier that patterns a gyrencephalic cortical surface. This matters mechanistically because it leaves open whether the human lissencephaly is (a) a downstream consequence of the same interneuron/migration lesion amplified in a gyrencephalic substrate, or (b) reflects an additional ARX requirement in human-enriched progenitor populations (bRG/oRG, or radial migration from the neocortical subventricular zone, as human XLAG neuropathology suggests) that is under-represented in the mouse. Model-derived evidence therefore validates the interneuronopathy branches strongly but systematically underdetermines the severity and existence of the human cortical-surface malformation.
Proposed experiments
ARX-null human iPSC MGE-cortex assembloid interneuron-migration and lamination assay
iPSC assembloid perturbation assay
exp_arx_human_cortical_assembloid
Generate isogenic ARX-null and control human iPSC-derived subpallial (MGE) and dorsal-cortical organoids, fuse them into assembloids, and quantify GABAergic interneuron specification, saltatory tangential migration into cortical tissue, and any radial-migration/lamination phenotype, testing whether human-enriched outer radial glia and the neocortical subventricular-zone radial-migration route (implicated by human XLAG neuropathology) contribute a cortical-surface phenotype absent from the apical-progenitor-dominated mouse cortex.
Model systems
Human iPSC-derived MGE-cortex assembloid
Fused subpallial and cortical organoids from gene-edited human iPSCs, preserving human-specific outer radial glia and OSVZ biology absent from the mouse and permitting direct assay of tangential interneuron migration into human cortical tissue.
ORGANOID
ARX perturbation in a gyrencephalic ferret cortex
in vivo gyrencephalic model study
exp_arx_gyrencephalic_ferret
Disrupt Arx in the developing ferret cortex, a gyrencephalic carnivore model possessing an OSVZ with oRG-like progenitors, and assess whether the interneuron deficit is accompanied by gyral simplification/agyria closer to the human XLAG lissencephaly than is seen in the natively agyric mouse, dissociating the conserved interneuronopathy from the gyrencephaly-specific cortical-surface phenotype.
Model systems
Gyrencephalic ferret cortex
Ferret (Mustela putorius furo) developing cortex, containing a prominent OSVZ with oRG-like progenitors, used as a bridge between the lissencephalic mouse and the gyrencephalic human cortex.
OTHER
Show evidence (2 references)
PMID:12379852 SUPPORT Model Organism
"These characteristics recapitulate some of the clinical features of X-linked lissencephaly with abnormal genitalia (XLAG) in humans."
The founding Arx knockout report explicitly qualifies the mouse as recapitulating only *some* human XLAG features (the interneuron-migration and genital arms), the wording that anchors the human-model mismatch for the defining lissencephaly phenotype.
PMID:17460091 SUPPORT Model Organism
"Both tangential migration toward the cortex and striatum and radial migration to the globus pallidus and striatum were greatly reduced in the mutants, causing a periventricular accumulation of NPY+ or calretinin+ neurons in the MGE."
Establishes that the Arx-null mouse faithfully reproduces the conserved tangential/radial interneuron-migration arm — the shared side of the mismatch — while the human gyrencephalic lissencephaly remains the divergent, non-phenocopied feature.

Pathophysiology

7
ARX Loss of Function and Subpallial Patterning Disruption
Loss-of-function mutations in ARX disrupt the paired-like homeodomain transcriptional-repressor programs that pattern the ventral telencephalon and specify cortical GABAergic interneuron lineages from ganglionic eminence-derived progenitor domains. This is the initiating molecular lesion of the ARX interneuronopathy and of XLAG at the severe end of the spectrum.
GABAergic interneuron CL:0011005
telencephalon development GO:0021537 ⚠ ABNORMAL forebrain development GO:0030900 ⚠ ABNORMAL
Show evidence (3 references)
PMID:17460091 SUPPORT Model Organism
"ARX loss-of-function mutations cause X-linked lissencephaly with ambiguous genitalia (XLAG), a severe neurological condition that results in profound brain malformations, including microcephaly, absence of corpus callosum, and impairment of the basal ganglia."
Establishes ARX loss of function as the upstream lesion producing the severe XLAG cortical-malformation phenotype that anchors this entry.
PMID:27287386 SUPPORT Model Organism
"Aristaless-related homeobox (ARX) is a paired-like homeodomain transcription factor that functions primarily as a transcriptional repressor and has been implicated in neocortical interneuron specification and migration."
Identifies ARX as a transcriptional repressor implicated in neocortical interneuron specification and migration, supporting the trigger as an interneuron lineage-program lesion rather than a generic lissencephaly label.
PMID:12379852 SUPPORT Model Organism
"Male embryonic mice with mutations in the X-linked aristaless-related homeobox gene (Arx) developed with small brains due to suppressed proliferation and regional deficiencies in the forebrain."
Demonstrates that Arx loss disrupts forebrain proliferation and regional patterning, consistent with a subpallial patterning lesion.
Interneuron Progenitor Specification and Differentiation Failure
ARX-deficient interneuron progenitors fail to execute normal GABAergic differentiation programs after early patterning, leaving immature neurons that accumulate in the ganglionic eminences instead of producing mature cortical inhibitory interneurons.
GABAergic interneuron CL:0011005 cortical interneuron CL:0008031
GABAergic neuron differentiation GO:0097154 ↓ DECREASED
Show evidence (2 references)
PMID:17460091 SUPPORT Model Organism
"In these animals, the early differentiation of this tissue appeared normal, whereas subsequent differentiation was impaired, leading to the periventricular accumulation of immature neurons in both the lateral ganglionic eminence and medial ganglionic eminence (MGE)."
Arx mutant mice show a post-patterning differentiation failure with immature neuron accumulation in ganglionic eminence domains.
PMID:20461390 SUPPORT Human Clinical
"The ganglionic eminences and basal ganglia were poorly cellular, suggesting an interneuron production and/or differentiation defect."
Human ARX-mutated lissencephaly tissue supports interneuron production and/or differentiation failure as a central ARX branch.
Tangential Migration Failure from Ganglionic Eminences
ARX-deficient interneuron precursors fail to migrate tangentially from the medial and lateral ganglionic eminences into the developing neocortex. XLAG is the prototypical human disorder demonstrating deficient tangential migration in the brain.
GABAergic interneuron CL:0011005
neuron migration GO:0001764 ↓ DECREASED
cerebral cortex UBERON:0000956
Show evidence (3 references)
PMID:17460091 SUPPORT Model Organism
"Both tangential migration toward the cortex and striatum and radial migration to the globus pallidus and striatum were greatly reduced in the mutants, causing a periventricular accumulation of NPY+ or calretinin+ neurons in the MGE."
Demonstrates reduced tangential migration from MGE-derived compartments in Arx mutant mice.
PMID:18458920 SUPPORT Human Clinical
"Our findings suggest that ARX protein controls not only the tangential migration of GABAergic interneurons from the ganglionic eminence, but also may serve to induce radial migration from the neocortical subventricular zone."
Human XLAG neuropathology supports ARX-dependent GABAergic interneuron migration from ganglionic eminence into neocortex.
PMID:15921244 SUPPORT Other
"X-linked lissencephaly with abnormal genitalia is the first human disorder in which deficient tangential migration in the brain has been demonstrated."
Frames XLAG as the human prototype of a tangential migration disorder, supporting interneuronopathy as the central ARX mechanism.
Cortical GABAergic Interneuron Deficit and Mislocalization
The developing ARX-mutant neocortex contains too few GABAergic interneurons, or interneurons arrested in the white matter and subventricular zone, impairing inhibitory circuit assembly. In severe human XLAG the cortical plate can be almost devoid of interneurons.
cerebral cortex GABAergic interneuron CL:0010011 cortical interneuron CL:0008031
GABAergic neuron differentiation GO:0097154 ↓ DECREASED
cerebral cortex UBERON:0000956
Show evidence (3 references)
PMID:18458920 SUPPORT Human Clinical
"We found that glutamic acid decarboxylase (GAD)- and calretinin (CR)-containing cells were significantly reduced in the neocortex and located in the white matter and neocortical subventricular zone, while neuropeptide Y- or cholecystokinin-containing cells were normally distributed."
Human XLAG tissue shows subtype-selective neocortical interneuron depletion and mislocalization.
PMID:20461390 SUPPORT Human Clinical
"In the ARX-mutated brain, the cortical plate contained almost exclusively pyramidal cells and was devoid of interneurons."
Human ARX-mutated lissencephaly tissue shows the severe cortical interneuron-loss phenotype.
PMID:27287386 SUPPORT Model Organism
"The result of this developmental shift is a reduced number of interneurons (all subtypes) at early postnatal and later time periods."
Conditional Arx loss in developing interneurons causes persistent cortical interneuron subtype deficits in mice.
Excitation-Inhibition Imbalance and Developmental Epilepsy
Cortical inhibitory circuit failure shifts excitation-inhibition balance and drives early-life seizures, ranging from the intractable neonatal seizures of XLAG to the infantile spasms/West syndrome of polyalanine-expansion ARX disease.
GABAergic neuron CL:0000617
gamma-aminobutyric acid signaling pathway GO:0007214 ↓ DECREASED synaptic transmission, GABAergic GO:0051932 ↓ DECREASED
Show evidence (2 references)
PMID:19439424 SUPPORT Model Organism
"Arx(-/y);Dlx5/6(CIG) (male) mice exhibit a variety of seizure types beginning in early-life, including seizures that behaviourally and electroencephalographically resembles infantile spasms, and show evolution through development."
Conditional Arx deletion from ganglionic eminence-derived neurons connects the interneuron branch to early-life developmental epilepsy and infantile-spasms-like seizures.
PMID:15921244 SUPPORT Other
"Male patients with X-linked lissencephaly with abnormal genitalia show intractable seizures, especially clonic convulsions or myoclonus from the first day of life, but neither infantile spasms nor hypsarrhythmia on electroencephalograms so far."
Human synthesis ties the XLAG interneuronopathy prototype to severe neonatal epileptogenicity.
Impaired Basal Ganglia Differentiation and Thalamocortical Wiring
Beyond the cortical interneuron branch, ARX loss impairs basal ganglia differentiation and the formation of thalamocortical axon tracts that must traverse the basal ganglia, contributing to the dysmorphic basal ganglia and diencephalic/thalamocortical abnormalities characteristic of XLAG. This is an ARX-specific branch not part of the shared interneuron module skeleton.
cholinergic neuron CL:0000108
striatum development GO:0021756 ⚠ ABNORMAL
basal ganglion UBERON:0002420
Show evidence (1 reference)
PMID:17460091 SUPPORT Model Organism
"Furthermore, Arx mutants lacked a large fraction of cholinergic neurons and displayed a strong impairment of thalamocortical projections, in which major axon fiber tracts failed to traverse the basal ganglia."
Demonstrates ARX-dependent basal ganglia differentiation and thalamocortical wiring defects in mice, recapitulating the dysmorphic basal ganglia of human XLAG.
Abnormal Forebrain and Genital Development
ARX is required outside the cortex for genital and testicular development, so loss of function produces the ambiguous or hypoplastic genitalia in hemizygous males that gives XLAG its name. This branch is ARX-specific and independent of the cortical interneuron skeleton.
male genitalia development GO:0030539 ⚠ ABNORMAL
Show evidence (2 references)
PMID:12379852 SUPPORT Model Organism
"These mice also showed aberrant migration and differentiation of interneurons containing gamma-aminobutyric acid (GABAergic interneurons) in the ganglionic eminence and neocortex as well as abnormal testicular differentiation."
Arx mutant mice show abnormal testicular differentiation alongside the interneuron migration defect, the model basis for the abnormal genitalia of human XLAG.
PMID:12379852 SUPPORT Human Clinical
"We found multiple loss-of-function mutations in ARX in individuals affected with XLAG and in some female relatives, and conclude that mutation of ARX causes XLAG."
Confirms loss-of-function ARX mutations as the cause of human XLAG, the syndrome defined by lissencephaly with abnormal genitalia.

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for ARX-Related Lissencephaly and Interneuronopathy Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.

Phenotypes

8
Head and Neck 1
Microcephaly Microcephaly HP:0000252
Show evidence (2 references)
PMID:14722918 SUPPORT Human Clinical
"A nonconservative missense mutation near the C-terminal aristaless domain caused unusually severe XLAG with microcephaly and mild cerebellar hypoplasia."
A large ARX genotype-phenotype series directly reports microcephaly in a severe XLAG presentation.
PMID:17460091 SUPPORT Model Organism
"ARX loss-of-function mutations cause X-linked lissencephaly with ambiguous genitalia (XLAG), a severe neurological condition that results in profound brain malformations, including microcephaly, absence of corpus callosum, and impairment of the basal ganglia."
The Arx mouse-model paper summarizes human XLAG as including microcephaly among the major brain malformations.
Nervous System 3
Agenesis of the Corpus Callosum Agenesis of corpus callosum HP:0001274
Show evidence (1 reference)
PMID:15921244 SUPPORT Other
"Brain magnetic resonance imaging shows anterior pachygyria and posterior agyria with a mildly thick cortex, agenesis of the corpus callosum, and dysplastic basal ganglia."
Documents corpus callosum agenesis as part of the XLAG imaging phenotype.
Dysmorphic Basal Ganglia Abnormal basal ganglia morphology HP:0002134
Show evidence (1 reference)
PMID:15921244 SUPPORT Other
"Brain magnetic resonance imaging shows anterior pachygyria and posterior agyria with a mildly thick cortex, agenesis of the corpus callosum, and dysplastic basal ganglia."
Documents dysplastic/dysmorphic basal ganglia as part of the XLAG imaging phenotype.
Intellectual Disability Intellectual disability HP:0001249
Show evidence (1 reference)
PMID:15921244 SUPPORT Other
"polyalanine expansion of ARX causes symptomatic or nonsymptomatic West's syndrome and nonsyndromic mental retardation"
Documents nonsyndromic intellectual disability (mental retardation) as the mild end of the ARX phenotypic spectrum.
Other 4
Lissencephaly Lissencephaly HP:0001339
Show evidence (1 reference)
PMID:15921244 SUPPORT Other
"Brain magnetic resonance imaging shows anterior pachygyria and posterior agyria with a mildly thick cortex, agenesis of the corpus callosum, and dysplastic basal ganglia."
Documents the agyria/pachygyria lissencephaly imaging phenotype of XLAG.
Ambiguous Genitalia Ambiguous genitalia HP:0000062
Show evidence (1 reference)
PMID:12379852 SUPPORT Human Clinical
"These characteristics recapitulate some of the clinical features of X-linked lissencephaly with abnormal genitalia (XLAG) in humans."
References the abnormal genitalia that define human XLAG, caused by ARX loss of function.
Intractable Neonatal Seizures Neonatal seizure HP:0032807
Onset: NEONATAL
Show evidence (1 reference)
PMID:15921244 SUPPORT Other
"Male patients with X-linked lissencephaly with abnormal genitalia show intractable seizures, especially clonic convulsions or myoclonus from the first day of life, but neither infantile spasms nor hypsarrhythmia on electroencephalograms so far."
Documents the intractable neonatal seizure phenotype of XLAG.
Infantile Spasms Infantile spasms HP:0012469
Show evidence (1 reference)
PMID:15921244 SUPPORT Other
"polyalanine expansion of ARX causes symptomatic or nonsymptomatic West's syndrome and nonsyndromic mental retardation"
Documents West syndrome (infantile spasms) as part of the ARX phenotypic spectrum produced by polyalanine-expansion variants.
🧬

Genetic Associations

1
ARX (Causative)
Gene: ARX (aristaless-related homeobox) hgnc:18060
X-linked inheritance
Show evidence (2 references)
PMID:12379852 SUPPORT Human Clinical
"We found multiple loss-of-function mutations in ARX in individuals affected with XLAG and in some female relatives, and conclude that mutation of ARX causes XLAG."
Founding report identifying loss-of-function ARX mutations as the cause of human XLAG.
PMID:14722918 SUPPORT Human Clinical
"Together, the group of phenotypes associated with ARX mutations demonstrates remarkable pleiotropy, but also comprises a nearly continuous series of developmental disorders that begins with hydranencephaly, lissencephaly, and agenesis of the corpus callosum, and ends with a series of overlapping..."
Establishes the striking pleiotropy and genotype-phenotype continuum of ARX mutations, the basis for modeling severe XLAG and milder presentations as one ARX pathomechanism with variant-class-dependent severity.
💊

Medical Actions

3
Anti-Seizure Medication
Action: pharmacotherapy Ontology label: Pharmacotherapy NCIT:C15986
Symptomatic management of the early, frequently intractable epilepsy of ARX-related disease with anti-seizure medications selected by seizure type (including hormonal/vigabatrin approaches for infantile spasms). No disease-modifying therapy exists; management is supportive.
Supportive and Rehabilitative Care
Action: supportive care MAXO:0000950
Multidisciplinary supportive care including physical, occupational, and developmental therapies for the severe motor and intellectual impairment.
Genetic Counseling
Action: Genetic Counseling NCIT:C15240
Genetic counseling for families, addressing X-linked inheritance, carrier female risk and variable carrier phenotypes, and recurrence risk; ARX variant class informs prognosis across the XLAG-to-nonsyndromic spectrum.
{ }

Source YAML

click to show
name: ARX-Related Lissencephaly and Interneuronopathy
creation_date: "2026-06-11T00:00:00Z"
category: Mendelian
disease_term:
  preferred_term: X-linked lissencephaly with abnormal genitalia (XLAG)
  term:
    id: MONDO:0010268
    label: X-linked lissencephaly with abnormal genitalia
inheritance:
- name: X-linked inheritance
  inheritance_term:
    preferred_term: X-linked inheritance
    term:
      id: HP:0001417
      label: X-linked inheritance
  evidence:
  - reference: PMID:12379852
    reference_title: "Mutation of ARX causes an X-linked human brain malformation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The present report is, to our knowledge, the first to use phenotypic
      analysis of a knockout mouse to identify a gene associated with an
      X-linked human brain malformation.
    explanation: >-
      The founding ARX/XLAG report identifies ARX as the gene for an X-linked
      human brain malformation.
description: >-
  ARX-related lissencephaly and interneuronopathy is an X-linked malformation of
  cortical development and developmental epilepsy spectrum caused by mutations in
  ARX, the aristaless-related homeobox gene, which encodes a paired-like
  homeodomain transcription factor that acts mainly as a transcriptional
  repressor in the ventral telencephalon. Unlike the radial-migration
  tubulinopathies and LIS1/DCX disorders, ARX disease is framed as an
  interneuronopathy: ARX governs subpallial patterning and the specification,
  differentiation, and tangential migration of GABAergic cortical interneurons
  from the ganglionic eminences into the developing neocortex. Loss of ARX
  function therefore depletes or mislocalizes cortical inhibitory interneurons,
  shifts cortical excitation-inhibition balance, and produces early, often
  intractable seizures. The most severe end of the spectrum is X-linked
  lissencephaly with abnormal genitalia (XLAG) in hemizygous males, with
  anterior pachygyria/posterior agyria, microcephaly, agenesis of the corpus
  callosum, dysmorphic basal ganglia, impaired thalamocortical wiring, ambiguous
  or hypoplastic genitalia, and intractable neonatal seizures. ARX mutations are
  strikingly pleiotropic, however, and the same gene produces a nearly
  continuous series of disorders ranging through hydranencephaly and
  lissencephaly to Proud syndrome (ACC with abnormal genitalia), X-linked
  infantile spasms/West syndrome, Partington syndrome, and nonsyndromic
  intellectual disability with structurally normal brains, with phenotype
  severity modulated by variant class (loss of function versus polyalanine
  expansion or homeodomain/nuclear-localization missense). The entry is modeled
  as a coherent ARX subpallial-patterning/interneuronopathy pathomechanism with
  XLAG as the prototype, and it conforms to the interneuron specification and
  tangential migration failure module.
parents:
- congenital nervous system disorder
- disorder of development or morphogenesis
- hereditary neurological disease
- neuronal migration disorder
references:
- reference: PMID:12379852
  title: "Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans."
- reference: PMID:17460091
  title: "Inactivation of Arx, the murine ortholog of the X-linked lissencephaly with ambiguous genitalia gene, leads to severe disorganization of the ventral telencephalon with impaired neuronal migration and differentiation."
- reference: PMID:15921244
  title: "X-linked lissencephaly with abnormal genitalia as a tangential migration disorder causing intractable epilepsy: proposal for a new term, interneuronopathy."
- reference: PMID:18458920
  title: "Aristaless-related homeobox gene disruption leads to abnormal distribution of GABAergic interneurons in human neocortex: evidence based on a case of X-linked lissencephaly with abnormal genitalia (XLAG)."
- reference: PMID:14722918
  title: "Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation."
- reference: PMID:19439424
  title: "Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females."
- reference: PMID:27287386
  title: "Developmental interneuron subtype deficits after targeted loss of Arx."
- reference: PMID:20461390
  title: "Evidence for tangential migration disturbances in human lissencephaly resulting from a defect in LIS1, DCX and ARX genes."
pathophysiology:
- name: ARX Loss of Function and Subpallial Patterning Disruption
  description: >-
    Loss-of-function mutations in ARX disrupt the paired-like homeodomain
    transcriptional-repressor programs that pattern the ventral telencephalon
    and specify cortical GABAergic interneuron lineages from ganglionic
    eminence-derived progenitor domains. This is the initiating molecular lesion
    of the ARX interneuronopathy and of XLAG at the severe end of the spectrum.
  conforms_to: "interneuron_specification_tangential_migration_failure#Subpallial Interneuron Lineage Program Disruption"
  role: trigger
  genes:
  - preferred_term: ARX
    term:
      id: hgnc:18060
      label: ARX
  cell_types:
  - preferred_term: GABAergic interneuron
    term:
      id: CL:0011005
      label: GABAergic interneuron
  biological_processes:
  - preferred_term: telencephalon development
    term:
      id: GO:0021537
      label: telencephalon development
    modifier: ABNORMAL
  - preferred_term: forebrain development
    term:
      id: GO:0030900
      label: forebrain development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:17460091
    reference_title: "Inactivation of Arx leads to severe disorganization of the ventral telencephalon with impaired neuronal migration and differentiation."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      ARX loss-of-function mutations cause X-linked lissencephaly with ambiguous
      genitalia (XLAG), a severe neurological condition that results in profound
      brain malformations, including microcephaly, absence of corpus callosum,
      and impairment of the basal ganglia.
    explanation: >-
      Establishes ARX loss of function as the upstream lesion producing the
      severe XLAG cortical-malformation phenotype that anchors this entry.
  - reference: PMID:27287386
    reference_title: "Conditional inactivation of Arx in developing interneurons."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Aristaless-related homeobox (ARX) is a paired-like homeodomain
      transcription factor that functions primarily as a transcriptional
      repressor and has been implicated in neocortical interneuron specification
      and migration.
    explanation: >-
      Identifies ARX as a transcriptional repressor implicated in neocortical
      interneuron specification and migration, supporting the trigger as an
      interneuron lineage-program lesion rather than a generic lissencephaly
      label.
  - reference: PMID:12379852
    reference_title: "Mutation of ARX causes abnormal development of forebrain and testes in mice and XLAG in humans."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Male embryonic mice with mutations in the X-linked aristaless-related
      homeobox gene (Arx) developed with small brains due to suppressed
      proliferation and regional deficiencies in the forebrain.
    explanation: >-
      Demonstrates that Arx loss disrupts forebrain proliferation and regional
      patterning, consistent with a subpallial patterning lesion.
  downstream:
  - target: Interneuron Progenitor Specification and Differentiation Failure
    description: >-
      Disrupted lineage programming reduces or distorts the interneuron
      progenitor pool produced in the ganglionic eminences.
  - target: Tangential Migration Failure from Ganglionic Eminences
    description: >-
      Disrupted lineage programming also impairs the migratory competence of
      interneuron precursors leaving the subpallium.
  - target: Impaired Basal Ganglia Differentiation and Thalamocortical Wiring
    description: >-
      ARX loss disrupts basal ganglia differentiation and the thalamocortical
      axon tracts that traverse the basal ganglia, an ARX-specific branch.
  - target: Abnormal Forebrain and Genital Development
    description: >-
      ARX is also required outside the cortex for genital/testicular
      development, producing the abnormal genitalia of XLAG in males.
- name: Interneuron Progenitor Specification and Differentiation Failure
  description: >-
    ARX-deficient interneuron progenitors fail to execute normal GABAergic
    differentiation programs after early patterning, leaving immature neurons
    that accumulate in the ganglionic eminences instead of producing mature
    cortical inhibitory interneurons.
  conforms_to: "interneuron_specification_tangential_migration_failure#Interneuron Progenitor Specification and Differentiation Failure"
  role: central_effector
  cell_types:
  - preferred_term: GABAergic interneuron
    term:
      id: CL:0011005
      label: GABAergic interneuron
  - preferred_term: cortical interneuron
    term:
      id: CL:0008031
      label: cortical interneuron
  biological_processes:
  - preferred_term: GABAergic neuron differentiation
    term:
      id: GO:0097154
      label: GABAergic neuron differentiation
    modifier: DECREASED
  evidence:
  - reference: PMID:17460091
    reference_title: "Inactivation of Arx leads to impaired neuronal migration and differentiation."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In these animals, the early differentiation of this tissue appeared
      normal, whereas subsequent differentiation was impaired, leading to the
      periventricular accumulation of immature neurons in both the lateral
      ganglionic eminence and medial ganglionic eminence (MGE).
    explanation: >-
      Arx mutant mice show a post-patterning differentiation failure with
      immature neuron accumulation in ganglionic eminence domains.
  - reference: PMID:20461390
    reference_title: "Tangential migration impairment in LIS1, DCX, and ARX lissencephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The ganglionic eminences and basal ganglia were poorly cellular,
      suggesting an interneuron production and/or differentiation defect.
    explanation: >-
      Human ARX-mutated lissencephaly tissue supports interneuron production
      and/or differentiation failure as a central ARX branch.
  downstream:
  - target: Cortical GABAergic Interneuron Deficit and Mislocalization
    description: >-
      Reduced interneuron generation lowers the number of inhibitory
      interneurons available to populate developing cortical circuits.
- name: Tangential Migration Failure from Ganglionic Eminences
  description: >-
    ARX-deficient interneuron precursors fail to migrate tangentially from the
    medial and lateral ganglionic eminences into the developing neocortex. XLAG
    is the prototypical human disorder demonstrating deficient tangential
    migration in the brain.
  conforms_to: "interneuron_specification_tangential_migration_failure#Tangential Migration Failure from Ganglionic Eminences"
  role: central_effector
  locations:
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  cell_types:
  - preferred_term: GABAergic interneuron
    term:
      id: CL:0011005
      label: GABAergic interneuron
  biological_processes:
  - preferred_term: neuron migration
    term:
      id: GO:0001764
      label: neuron migration
    modifier: DECREASED
  evidence:
  - reference: PMID:17460091
    reference_title: "Inactivation of Arx: greatly reduced tangential and radial migration."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Both tangential migration toward the cortex and striatum and radial
      migration to the globus pallidus and striatum were greatly reduced in the
      mutants, causing a periventricular accumulation of NPY+ or calretinin+
      neurons in the MGE.
    explanation: >-
      Demonstrates reduced tangential migration from MGE-derived compartments in
      Arx mutant mice.
  - reference: PMID:18458920
    reference_title: "Mutant ARX: abnormal distribution of GABAergic interneurons in human neocortex."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our findings suggest that ARX protein controls not only the tangential
      migration of GABAergic interneurons from the ganglionic eminence, but also
      may serve to induce radial migration from the neocortical subventricular
      zone.
    explanation: >-
      Human XLAG neuropathology supports ARX-dependent GABAergic interneuron
      migration from ganglionic eminence into neocortex.
  - reference: PMID:15921244
    reference_title: "XLAG as a tangential migration disorder: proposal for interneuronopathy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      X-linked lissencephaly with abnormal genitalia is the first human disorder
      in which deficient tangential migration in the brain has been demonstrated.
    explanation: >-
      Frames XLAG as the human prototype of a tangential migration disorder,
      supporting interneuronopathy as the central ARX mechanism.
  downstream:
  - target: Cortical GABAergic Interneuron Deficit and Mislocalization
    description: >-
      Migration failure produces regionally depleted or misplaced cortical
      inhibitory interneurons even when some progenitors are generated.
  - target: Lissencephaly
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - abnormal cortical neuronal migration
    - disrupted cortical lamination
    description: Defective ARX-dependent neuronal migration contributes to the agyria-pachygyria lissencephaly pattern of XLAG.
- name: Cortical GABAergic Interneuron Deficit and Mislocalization
  description: >-
    The developing ARX-mutant neocortex contains too few GABAergic interneurons,
    or interneurons arrested in the white matter and subventricular zone,
    impairing inhibitory circuit assembly. In severe human XLAG the cortical
    plate can be almost devoid of interneurons.
  conforms_to: "interneuron_specification_tangential_migration_failure#Cortical GABAergic Interneuron Deficit or Mislocalization"
  role: effector
  locations:
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  cell_types:
  - preferred_term: cerebral cortex GABAergic interneuron
    term:
      id: CL:0010011
      label: cerebral cortex GABAergic interneuron
  - preferred_term: cortical interneuron
    term:
      id: CL:0008031
      label: cortical interneuron
  biological_processes:
  - preferred_term: GABAergic neuron differentiation
    term:
      id: GO:0097154
      label: GABAergic neuron differentiation
    modifier: DECREASED
  evidence:
  - reference: PMID:18458920
    reference_title: "Mutant ARX: reduced GAD/calretinin neocortical interneurons."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We found that glutamic acid decarboxylase (GAD)- and calretinin
      (CR)-containing cells were significantly reduced in the neocortex and
      located in the white matter and neocortical subventricular zone, while
      neuropeptide Y- or cholecystokinin-containing cells were normally
      distributed.
    explanation: >-
      Human XLAG tissue shows subtype-selective neocortical interneuron
      depletion and mislocalization.
  - reference: PMID:20461390
    reference_title: "Tangential migration impairment in ARX lissencephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In the ARX-mutated brain, the cortical plate contained almost exclusively
      pyramidal cells and was devoid of interneurons.
    explanation: >-
      Human ARX-mutated lissencephaly tissue shows the severe cortical
      interneuron-loss phenotype.
  - reference: PMID:27287386
    reference_title: "Conditional Arx loss: reduced interneurons of all subtypes."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The result of this developmental shift is a reduced number of interneurons
      (all subtypes) at early postnatal and later time periods.
    explanation: >-
      Conditional Arx loss in developing interneurons causes persistent cortical
      interneuron subtype deficits in mice.
  downstream:
  - target: Excitation-Inhibition Imbalance and Developmental Epilepsy
    description: >-
      Deficient inhibitory interneuron integration reduces inhibitory tone and
      destabilizes cortical network activity.
  - target: Intellectual Disability
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - inhibitory circuit maldevelopment
    - developmental epileptic encephalopathy
    description: Cortical inhibitory circuit failure impairs neurodevelopmental function across the ARX spectrum.
- name: Excitation-Inhibition Imbalance and Developmental Epilepsy
  description: >-
    Cortical inhibitory circuit failure shifts excitation-inhibition balance and
    drives early-life seizures, ranging from the intractable neonatal seizures
    of XLAG to the infantile spasms/West syndrome of polyalanine-expansion ARX
    disease.
  conforms_to: "interneuron_specification_tangential_migration_failure#Excitation-Inhibition Imbalance and Developmental Epilepsy"
  role: outcome
  cell_types:
  - preferred_term: GABAergic neuron
    term:
      id: CL:0000617
      label: GABAergic neuron
  biological_processes:
  - preferred_term: gamma-aminobutyric acid signaling pathway
    term:
      id: GO:0007214
      label: gamma-aminobutyric acid signaling pathway
    modifier: DECREASED
  - preferred_term: synaptic transmission, GABAergic
    term:
      id: GO:0051932
      label: synaptic transmission, GABAergic
    modifier: DECREASED
  evidence:
  - reference: PMID:19439424
    reference_title: "Targeted Arx deletion from ganglionic eminence-derived neurons causes developmental epilepsy."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Arx(-/y);Dlx5/6(CIG) (male) mice exhibit a variety of seizure types
      beginning in early-life, including seizures that behaviourally and
      electroencephalographically resembles infantile spasms, and show evolution
      through development.
    explanation: >-
      Conditional Arx deletion from ganglionic eminence-derived neurons connects
      the interneuron branch to early-life developmental epilepsy and
      infantile-spasms-like seizures.
  - reference: PMID:15921244
    reference_title: "XLAG: intractable seizures from the first day of life."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Male patients with X-linked lissencephaly with abnormal genitalia show
      intractable seizures, especially clonic convulsions or myoclonus from the
      first day of life, but neither infantile spasms nor hypsarrhythmia on
      electroencephalograms so far.
    explanation: >-
      Human synthesis ties the XLAG interneuronopathy prototype to severe
      neonatal epileptogenicity.
  downstream:
  - target: Intractable Neonatal Seizures
    causal_link_type: DIRECT
    description: Early-life excitation-inhibition imbalance manifests as intractable neonatal seizures in XLAG.
  - target: Infantile Spasms
    causal_link_type: DIRECT
    description: Milder ARX-spectrum inhibitory circuit dysfunction can manifest as infantile spasms or West syndrome.
- name: Impaired Basal Ganglia Differentiation and Thalamocortical Wiring
  description: >-
    Beyond the cortical interneuron branch, ARX loss impairs basal ganglia
    differentiation and the formation of thalamocortical axon tracts that must
    traverse the basal ganglia, contributing to the dysmorphic basal ganglia and
    diencephalic/thalamocortical abnormalities characteristic of XLAG. This is an
    ARX-specific branch not part of the shared interneuron module skeleton.
  role: effector
  locations:
  - preferred_term: basal ganglion
    term:
      id: UBERON:0002420
      label: basal ganglion
  cell_types:
  - preferred_term: cholinergic neuron
    term:
      id: CL:0000108
      label: cholinergic neuron
  biological_processes:
  - preferred_term: striatum development
    term:
      id: GO:0021756
      label: striatum development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:17460091
    reference_title: "Inactivation of Arx: loss of cholinergic neurons and impaired thalamocortical projections."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Furthermore, Arx mutants lacked a large fraction of cholinergic neurons
      and displayed a strong impairment of thalamocortical projections, in which
      major axon fiber tracts failed to traverse the basal ganglia.
    explanation: >-
      Demonstrates ARX-dependent basal ganglia differentiation and
      thalamocortical wiring defects in mice, recapitulating the dysmorphic
      basal ganglia of human XLAG.
  downstream:
  - target: Dysmorphic Basal Ganglia
    causal_link_type: DIRECT
    description: Impaired basal ganglia differentiation produces the dysplastic basal ganglia imaging phenotype.
- name: Abnormal Forebrain and Genital Development
  description: >-
    ARX is required outside the cortex for genital and testicular development, so
    loss of function produces the ambiguous or hypoplastic genitalia in
    hemizygous males that gives XLAG its name. This branch is ARX-specific and
    independent of the cortical interneuron skeleton.
  role: effector
  biological_processes:
  - preferred_term: male genitalia development
    term:
      id: GO:0030539
      label: male genitalia development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:12379852
    reference_title: "Mutation of ARX causes abnormal development of forebrain and testes in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      These mice also showed aberrant migration and differentiation of
      interneurons containing gamma-aminobutyric acid (GABAergic interneurons)
      in the ganglionic eminence and neocortex as well as abnormal testicular
      differentiation.
    explanation: >-
      Arx mutant mice show abnormal testicular differentiation alongside the
      interneuron migration defect, the model basis for the abnormal genitalia
      of human XLAG.
  - reference: PMID:12379852
    reference_title: "Loss-of-function ARX mutations cause XLAG in humans."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We found multiple loss-of-function mutations in ARX in individuals
      affected with XLAG and in some female relatives, and conclude that mutation
      of ARX causes XLAG.
    explanation: >-
      Confirms loss-of-function ARX mutations as the cause of human XLAG, the
      syndrome defined by lissencephaly with abnormal genitalia.
  downstream:
  - target: Ambiguous Genitalia
    causal_link_type: DIRECT
    description: ARX-dependent genital and testicular developmental disruption produces ambiguous or hypoplastic genitalia in XLAG.
  - target: Microcephaly
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - reduced forebrain proliferation
    - regional forebrain deficiencies
    description: Forebrain proliferative and patterning defects contribute to microcephaly in severe ARX loss-of-function disease.
  - target: Agenesis of the Corpus Callosum
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - abnormal commissural development
    - forebrain patterning disruption
    description: ARX-related forebrain maldevelopment contributes to corpus callosum agenesis.
phenotypes:
- name: Lissencephaly
  description: >-
    Anterior pachygyria with posterior agyria and a mildly thickened cortex is
    the core cortical malformation of XLAG, at the severe end of the ARX
    spectrum.
  phenotype_term:
    preferred_term: Lissencephaly
    term:
      id: HP:0001339
      label: Lissencephaly
  evidence:
  - reference: PMID:15921244
    reference_title: "XLAG MRI: anterior pachygyria and posterior agyria."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Brain magnetic resonance imaging shows anterior pachygyria and posterior
      agyria with a mildly thick cortex, agenesis of the corpus callosum, and
      dysplastic basal ganglia.
    explanation: >-
      Documents the agyria/pachygyria lissencephaly imaging phenotype of XLAG.
- name: Agenesis of the Corpus Callosum
  description: >-
    Agenesis of the corpus callosum is a consistent commissural abnormality in
    XLAG and in the related Proud syndrome end of the ARX spectrum.
  phenotype_term:
    preferred_term: Agenesis of corpus callosum
    term:
      id: HP:0001274
      label: Agenesis of corpus callosum
  evidence:
  - reference: PMID:15921244
    reference_title: "XLAG MRI: agenesis of the corpus callosum."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Brain magnetic resonance imaging shows anterior pachygyria and posterior
      agyria with a mildly thick cortex, agenesis of the corpus callosum, and
      dysplastic basal ganglia.
    explanation: >-
      Documents corpus callosum agenesis as part of the XLAG imaging phenotype.
- name: Dysmorphic Basal Ganglia
  description: >-
    Dysplastic basal ganglia, reflecting impaired ARX-dependent basal ganglia
    differentiation, are a characteristic imaging feature of XLAG.
  phenotype_term:
    preferred_term: Abnormal basal ganglia morphology
    term:
      id: HP:0002134
      label: Abnormal basal ganglia morphology
  evidence:
  - reference: PMID:15921244
    reference_title: "XLAG MRI: dysplastic basal ganglia."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Brain magnetic resonance imaging shows anterior pachygyria and posterior
      agyria with a mildly thick cortex, agenesis of the corpus callosum, and
      dysplastic basal ganglia.
    explanation: >-
      Documents dysplastic/dysmorphic basal ganglia as part of the XLAG imaging
      phenotype.
- name: Microcephaly
  description: >-
    Microcephaly is part of the severe XLAG brain-malformation phenotype and is
    also noted in severe ARX genotype-phenotype series.
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:14722918
    reference_title: "ARX mutations and genotype-phenotype correlation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A nonconservative missense mutation near the C-terminal aristaless domain
      caused unusually severe XLAG with microcephaly and mild cerebellar
      hypoplasia.
    explanation: >-
      A large ARX genotype-phenotype series directly reports microcephaly in a
      severe XLAG presentation.
  - reference: PMID:17460091
    reference_title: "ARX loss of function causes XLAG with microcephaly."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      ARX loss-of-function mutations cause X-linked lissencephaly with ambiguous
      genitalia (XLAG), a severe neurological condition that results in profound
      brain malformations, including microcephaly, absence of corpus callosum,
      and impairment of the basal ganglia.
    explanation: >-
      The Arx mouse-model paper summarizes human XLAG as including microcephaly
      among the major brain malformations.
- name: Ambiguous Genitalia
  description: >-
    Ambiguous or hypoplastic genitalia in hemizygous males is the defining
    extracerebral feature that gives X-linked lissencephaly with abnormal
    genitalia its name.
  phenotype_term:
    preferred_term: Ambiguous genitalia
    term:
      id: HP:0000062
      label: Ambiguous genitalia
  evidence:
  - reference: PMID:12379852
    reference_title: "Mutation of ARX causes XLAG with abnormal genitalia in humans."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These characteristics recapitulate some of the clinical features of
      X-linked lissencephaly with abnormal genitalia (XLAG) in humans.
    explanation: >-
      References the abnormal genitalia that define human XLAG, caused by ARX
      loss of function.
- name: Intractable Neonatal Seizures
  description: >-
    Intractable seizures, typically clonic convulsions or myoclonus from the
    first day of life, are a hallmark of XLAG and reflect the cortical
    interneuron deficit.
  phenotype_term:
    preferred_term: Neonatal seizure
    term:
      id: HP:0032807
      label: Neonatal seizure
    onset:
      onset_category: NEONATAL
  evidence:
  - reference: PMID:15921244
    reference_title: "XLAG: intractable seizures from the first day of life."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Male patients with X-linked lissencephaly with abnormal genitalia show
      intractable seizures, especially clonic convulsions or myoclonus from the
      first day of life, but neither infantile spasms nor hypsarrhythmia on
      electroencephalograms so far.
    explanation: >-
      Documents the intractable neonatal seizure phenotype of XLAG.
- name: Infantile Spasms
  description: >-
    Polyalanine-expansion ARX mutations cause X-linked infantile spasms/West
    syndrome at the milder end of the spectrum, distinct from the agyria of XLAG.
  phenotype_term:
    preferred_term: Infantile spasms
    term:
      id: HP:0012469
      label: Infantile spasms
  evidence:
  - reference: PMID:15921244
    reference_title: "ARX polyalanine expansion causes West syndrome."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      polyalanine expansion of ARX causes symptomatic or nonsymptomatic West's
      syndrome and nonsyndromic mental retardation
    explanation: >-
      Documents West syndrome (infantile spasms) as part of the ARX phenotypic
      spectrum produced by polyalanine-expansion variants.
- name: Intellectual Disability
  description: >-
    Nonsyndromic intellectual disability, with structurally normal brains, is the
    mildest recurrent ARX presentation and part of the ARX pleiotropic spectrum.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:15921244
    reference_title: "ARX polyalanine expansion causes nonsyndromic mental retardation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      polyalanine expansion of ARX causes symptomatic or nonsymptomatic West's
      syndrome and nonsyndromic mental retardation
    explanation: >-
      Documents nonsyndromic intellectual disability (mental retardation) as the
      mild end of the ARX phenotypic spectrum.
genetic:
- name: ARX
  association: Causative
  gene_term:
    preferred_term: ARX (aristaless-related homeobox)
    term:
      id: hgnc:18060
      label: ARX
  inheritance:
  - name: X-linked inheritance
    inheritance_term:
      preferred_term: X-linked inheritance
      term:
        id: HP:0001417
        label: X-linked inheritance
  evidence:
  - reference: PMID:12379852
    reference_title: "Loss-of-function ARX mutations cause XLAG."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We found multiple loss-of-function mutations in ARX in individuals
      affected with XLAG and in some female relatives, and conclude that mutation
      of ARX causes XLAG.
    explanation: >-
      Founding report identifying loss-of-function ARX mutations as the cause of
      human XLAG.
  - reference: PMID:14722918
    reference_title: "Mutations of ARX are associated with striking pleiotropy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Together, the group of phenotypes associated with ARX mutations
      demonstrates remarkable pleiotropy, but also comprises a nearly continuous
      series of developmental disorders that begins with hydranencephaly,
      lissencephaly, and agenesis of the corpus callosum, and ends with a series
      of overlapping syndromes with apparently normal brain structure.
    explanation: >-
      Establishes the striking pleiotropy and genotype-phenotype continuum of
      ARX mutations, the basis for modeling severe XLAG and milder presentations
      as one ARX pathomechanism with variant-class-dependent severity.
treatments:
- name: Anti-Seizure Medication
  description: >-
    Symptomatic management of the early, frequently intractable epilepsy of
    ARX-related disease with anti-seizure medications selected by seizure type
    (including hormonal/vigabatrin approaches for infantile spasms). No
    disease-modifying therapy exists; management is supportive.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
- name: Supportive and Rehabilitative Care
  description: >-
    Multidisciplinary supportive care including physical, occupational, and
    developmental therapies for the severe motor and intellectual impairment.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
- name: Genetic Counseling
  description: >-
    Genetic counseling for families, addressing X-linked inheritance, carrier
    female risk and variable carrier phenotypes, and recurrence risk; ARX
    variant class informs prognosis across the XLAG-to-nonsyndromic spectrum.
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
discussions:
- discussion_id: gap_arx_mouse_lissencephaly_gyrencephaly_mismatch
  prompt: >-
    Does the Arx-null mouse — the founding and principal animal model of
    ARX-related disease — faithfully recapitulate the defining human XLAG
    cortical malformation, or does the fact that the mouse is a natively
    lissencephalic (agyric) species, lacking the expanded outer subventricular
    zone (OSVZ) and outer radial glia (oRG) that drive gyrencephalic cortical
    surface expansion in humans, mean that the model robustly reproduces the
    subpallial interneuronopathy, tangential-migration, basal-ganglia and
    genital arms but cannot phenocopy the anterior-pachygyria/posterior-agyria
    "lissencephaly" that gives XLAG its name?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#ARX Loss of Function and Subpallial Patterning Disruption
  - pathophysiology#Tangential Migration Failure from Ganglionic Eminences
  rationale: >-
    The Arx-null mouse establishes the causal logic of this entry: it reproduces
    the disrupted subpallial patterning, the impaired tangential and radial
    migration of ganglionic-eminence-derived GABAergic interneurons, the
    basal-ganglia/thalamocortical wiring defects, the abnormal testicular
    differentiation, and the developmental epilepsy — i.e., the interneuronopathy
    skeleton that this entry conforms to. However, the founding report itself is
    careful to state that the mouse recapitulates only *some* of the human
    features, and the cardinal human XLAG neuroradiological lesion — a mildly
    thickened agyric/pachygyric cortex (lissencephaly) — is precisely the arm the
    rodent cannot phenocopy, because a baseline-agyric mouse cortex has no gyral
    architecture to lose and lacks the human-enriched OSVZ/oRG amplification tier
    that patterns a gyrencephalic cortical surface. This matters mechanistically
    because it leaves open whether the human lissencephaly is (a) a downstream
    consequence of the same interneuron/migration lesion amplified in a
    gyrencephalic substrate, or (b) reflects an additional ARX requirement in
    human-enriched progenitor populations (bRG/oRG, or radial migration from the
    neocortical subventricular zone, as human XLAG neuropathology suggests) that
    is under-represented in the mouse. Model-derived evidence therefore validates
    the interneuronopathy branches strongly but systematically underdetermines
    the severity and existence of the human cortical-surface malformation.
  proposed_experiments:
  - experiment_id: exp_arx_human_cortical_assembloid
    name: ARX-null human iPSC MGE-cortex assembloid interneuron-migration and lamination assay
    description: >-
      Generate isogenic ARX-null and control human iPSC-derived subpallial
      (MGE) and dorsal-cortical organoids, fuse them into assembloids, and
      quantify GABAergic interneuron specification, saltatory tangential
      migration into cortical tissue, and any radial-migration/lamination
      phenotype, testing whether human-enriched outer radial glia and the
      neocortical subventricular-zone radial-migration route (implicated by
      human XLAG neuropathology) contribute a cortical-surface phenotype absent
      from the apical-progenitor-dominated mouse cortex.
    experiment_type:
      preferred_term: iPSC assembloid perturbation assay
    model_systems:
    - name: Human iPSC-derived MGE-cortex assembloid
      description: >-
        Fused subpallial and cortical organoids from gene-edited human iPSCs,
        preserving human-specific outer radial glia and OSVZ biology absent from
        the mouse and permitting direct assay of tangential interneuron
        migration into human cortical tissue.
      experimental_model_type: ORGANOID
  - experiment_id: exp_arx_gyrencephalic_ferret
    name: ARX perturbation in a gyrencephalic ferret cortex
    description: >-
      Disrupt Arx in the developing ferret cortex, a gyrencephalic carnivore
      model possessing an OSVZ with oRG-like progenitors, and assess whether the
      interneuron deficit is accompanied by gyral simplification/agyria closer
      to the human XLAG lissencephaly than is seen in the natively agyric mouse,
      dissociating the conserved interneuronopathy from the gyrencephaly-specific
      cortical-surface phenotype.
    experiment_type:
      preferred_term: in vivo gyrencephalic model study
    model_systems:
    - name: Gyrencephalic ferret cortex
      description: >-
        Ferret (Mustela putorius furo) developing cortex, containing a prominent
        OSVZ with oRG-like progenitors, used as a bridge between the
        lissencephalic mouse and the gyrencephalic human cortex.
      experimental_model_type: OTHER
  evidence:
  - reference: PMID:12379852
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      These characteristics recapitulate some of the clinical features of
      X-linked lissencephaly with abnormal genitalia (XLAG) in humans.
    explanation: >-
      The founding Arx knockout report explicitly qualifies the mouse as
      recapitulating only *some* human XLAG features (the interneuron-migration
      and genital arms), the wording that anchors the human-model mismatch for
      the defining lissencephaly phenotype.
  - reference: PMID:17460091
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Both tangential migration toward the cortex and striatum and radial
      migration to the globus pallidus and striatum were greatly reduced in the
      mutants, causing a periventricular accumulation of NPY+ or calretinin+
      neurons in the MGE.
    explanation: >-
      Establishes that the Arx-null mouse faithfully reproduces the conserved
      tangential/radial interneuron-migration arm — the shared side of the
      mismatch — while the human gyrencephalic lissencephaly remains the
      divergent, non-phenocopied feature.
notes: >-
  Entry created from cortical-malformation epic 4098 (issue 4082), seeded from
  Romero, Bahi-Buisson & Francis 2018 (Sem Cell Dev Biol 76:33-75). Scope
  decision: modeled as a coherent ARX subpallial-patterning/interneuronopathy
  pathomechanism with XLAG (MONDO:0010268) as the prototype/severe end, rather
  than as a generic lissencephaly entry or as several split single-syndrome
  entries. The shared ARX mechanism skeleton — disrupted subpallial interneuron
  lineage programming, interneuron specification/differentiation failure,
  tangential migration failure, cortical GABAergic interneuron deficit, and
  excitation-inhibition imbalance/developmental epilepsy — conforms to
  kb/modules/interneuron_specification_tangential_migration_failure.yaml. Two
  ARX-specific branches (basal ganglia differentiation/thalamocortical wiring and
  forebrain/genital development) are kept in this entry and not pushed to the
  module, per the module's note that ARX genital, callosal, and basal-ganglia
  branches belong in ARX disease entries. ARX is strikingly pleiotropic: variant
  class modulates severity (loss of function and homeodomain/nuclear-localization
  missense at the severe XLAG/lissencephaly end; polyalanine expansion at the
  West syndrome/Partington/nonsyndromic-ID end). Variant-to-branch mapping
  (e.g., IPO13 sequestration of NLS missense, residual function of N-terminal
  truncating/reinitiation variants) is captured as open knowledge gaps in the
  conformance module's discussions and may be added here as evidence as the
  spectrum is further curated. PubMed searches for an ARX GeneReviews baseline
  did not identify a GeneReviews PMID. Well-established clinical features
  without a quotable abstract snippet in the cited papers (dystonia, severe
  global developmental delay, early lethality in classic XLAG) are summarized in
  the description rather than asserted as separately evidenced phenotypes,
  pending sources with exact quotable text.
📚

References & Deep Research

References

8
Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans.
No top-level findings curated for this source.
Inactivation of Arx, the murine ortholog of the X-linked lissencephaly with ambiguous genitalia gene, leads to severe disorganization of the ventral telencephalon with impaired neuronal migration and differentiation.
No top-level findings curated for this source.
X-linked lissencephaly with abnormal genitalia as a tangential migration disorder causing intractable epilepsy: proposal for a new term, interneuronopathy.
No top-level findings curated for this source.
Aristaless-related homeobox gene disruption leads to abnormal distribution of GABAergic interneurons in human neocortex: evidence based on a case of X-linked lissencephaly with abnormal genitalia (XLAG).
No top-level findings curated for this source.
Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation.
No top-level findings curated for this source.
Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females.
No top-level findings curated for this source.
Developmental interneuron subtype deficits after targeted loss of Arx.
No top-level findings curated for this source.
Evidence for tangential migration disturbances in human lissencephaly resulting from a defect in LIS1, DCX and ARX genes.
No top-level findings curated for this source.

Deep Research

1
Falcon
ARX-Related Lissencephaly and Interneuronopathy (XLAG): Comprehensive Disease Characteristics Report
Edison Scientific Literature 35 citations 2026-06-11T18:45:42.413957

ARX-Related Lissencephaly and Interneuronopathy (XLAG): Comprehensive Disease Characteristics Report

Target disease

Disease name: ARX-Related Lissencephaly and Interneuronopathy (classically X-linked lissencephaly with abnormal/ambiguous genitalia, XLAG) (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, drongitis2022deregulationofmicrotubule pages 1-3).

Scope note: Much of the clinical literature uses XLAG for the severe malformation phenotype (lissencephaly + callosal agenesis + ambiguous genitalia + neonatal epileptic encephalopathy) due to hemizygous loss-of-function ARX variants in males (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, drongitis2022deregulationofmicrotubule pages 1-3). ARX also causes a broader spectrum of ARX-related developmental and epileptic encephalopathies (DEE) and intellectual disability (ID), including phenotypes without major malformations (eksioglu2011anovelmutation pages 6-7, bernardo2024xlinkedepilepsiesa pages 17-19).


1. Disease information

1.1 Concise overview

ARX-related lissencephaly/interneuronopathy (XLAG) is a rare X-linked neurodevelopmental malformation syndrome caused by pathogenic variants in ARX, characterized by lissencephaly/pachygyria, agenesis of the corpus callosum (ACC), abnormal/ambiguous male genitalia, and neonatal-onset medically refractory seizures with severe developmental impairment and high early mortality (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, spinosa2006lissencephalyabnormalgenitalia pages 1-3, ffrenchconstant2019fetalandneonatal pages 3-4).

Neuropathologically, the cortex is often described as three-layered with a marked deficit of cortical GABAergic interneurons, motivating the “interneuronopathy” concept in ARX-related lissencephaly (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, ffrenchconstant2019fetalandneonatal pages 3-4).

1.2 Key identifiers and synonyms

OMIM/MIM disease: 300215 (XLAG) (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, drongitis2022deregulationofmicrotubule pages 1-3).
OMIM/MIM gene: ARX 300382 (drongitis2022deregulationofmicrotubule pages 1-3).
Common synonyms/alternative names: “X-linked lissencephaly with abnormal genitalia”, “X-linked lissencephaly with ambiguous genitalia”, “X-linked lissencephaly with ACC and abnormal/ambiguous genitalia”, “lissencephaly X-linked 2” (drongitis2022deregulationofmicrotubule pages 1-3, bernardo2024xlinkedepilepsiesa pages 3-4).

Ontology gaps: Within the tool-accessible literature set, explicit MONDO, Orphanet, ICD-10/ICD-11, and MeSH identifiers for XLAG were not directly extractable; mapping should be performed using OMIM 300215 and ARX OMIM 300382 as anchors.

1.3 Evidence provenance

The information here is derived primarily from aggregated disease-level resources (reviews, cohort/literature syntheses) plus individual case reports and neuropathology studies (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, gras2024furthercharacterisationof pages 1-3, bernardo2024xlinkedepilepsiesa pages 17-19, ffrenchconstant2019fetalandneonatal pages 1-3).

Summary identifier table: | Primary disease name | Disease OMIM/MIM | Causal gene | Gene OMIM/MIM | Genomic locus reported | Common synonyms / alternative names | Key defining features | Best supporting citations | |---|---:|---|---:|---|---|---|---| | ARX-related lissencephaly and interneuronopathy | 300215 | ARX | 300382 | Xp22.13; Xp21.3 reported in recent review/case literature | X-linked lissencephaly with abnormal genitalia (XLAG); X-linked lissencephaly with ambiguous genitalia; X-linked lissencephaly with agenesis of the corpus callosum and abnormal/ambiguous genitalia; lissencephaly X-linked 2 | Lissencephaly/pachygyria, agenesis of the corpus callosum (ACC), ambiguous/abnormal male genitalia, neonatal-onset refractory/intractable seizures/epilepsy | (drongitis2022deregulationofmicrotubule pages 1-3, gras2024furthercharacterisationof pages 1-3, bernardo2024xlinkedepilepsiesa pages 17-19, bernardo2024xlinkedepilepsiesa pages 3-4) | | XLAG | 300215 | ARX | 300382 | Xp22.13 | X-linked lissencephaly with abnormal genitalia; X-linked lissencephaly with ambiguous genitalia | Posterior-predominant lissencephaly or diffuse pachygyria with relatively thick cortex, ACC/callosal agenesis, micropenis/cryptorchidism or genital ambiguity, severe neonatal epileptic encephalopathy | (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, spinosa2006lissencephalyabnormalgenitalia pages 1-3, ffrenchconstant2019fetalandneonatal pages 3-4) | | ARX-related lissencephaly | 300215 | ARX | 300382 | X chromosome, Xp21.3/Xp22.13 as cited | ARX-related XLAG; ARX-associated lissencephaly; lissencephaly X-linked 2 | Three-layered cortex with interneuron deficit, small basal ganglia, corpus callosum agenesis, neonatal refractory seizures, severe developmental impairment | (ffrenchconstant2019fetalandneonatal pages 1-3, ffrenchconstant2019fetalandneonatal pages 3-4) |

Table: This table summarizes the core disease identifiers, synonyms, loci, and defining features for ARX-related lissencephaly/interneuronopathy (XLAG). It is useful as a compact normalization reference for disease knowledge base entries and ontology mapping.


2. Etiology

2.1 Disease causal factors

Primary cause: Germline pathogenic variants in ARX (X chromosome), encoding a transcription factor critical for brain development and interneuron generation/migration (drongitis2022deregulationofmicrotubule pages 1-3, bernardo2024xlinkedepilepsiesa pages 17-19).

Mechanistic cause: Disrupted transcriptional programs in ventral telencephalic progenitors and developing interneurons, leading to abnormal development and tangential migration of GABAergic interneurons, with downstream network hyperexcitability (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, ffrenchconstant2019fetalandneonatal pages 3-4).

2.2 Risk factors

Genetic: Hemizygous loss-of-function variants in ARX in 46,XY individuals drive the classic XLAG phenotype (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, drongitis2022deregulationofmicrotubule pages 1-3). In females, heterozygous ARX variants show variable expressivity influenced by X-inactivation (bernardo2024xlinkedepilepsiesa pages 17-19, gras2024furthercharacterisationof pages 15-15).

Environmental: No specific environmental risk factors for XLAG were identified in the retrieved evidence.

2.3 Protective factors / gene–environment interactions

No protective factors or gene–environment interactions specific to XLAG were identified in the retrieved evidence.


3. Phenotypes

3.1 Core clinical phenotype (XLAG)

Neurologic: lissencephaly/pachygyria; ACC; neonatal-onset intractable epilepsy; severe developmental impairment; acquired/postnatal microcephaly described in cases (spinosa2006lissencephalyabnormalgenitalia pages 1-3, okazaki2008aristalessrelatedhomeoboxgene pages 1-2, ffrenchconstant2019fetalandneonatal pages 3-4).
Genital: ambiguous genitalia in 46,XY males (e.g., micropenis, cryptorchidism) (spinosa2006lissencephalyabnormalgenitalia pages 1-3, okazaki2008aristalessrelatedhomeoboxgene pages 1-2).
Other recurrent features: temperature instability/hypothalamic dysfunction and chronic diarrhea/pancreatic dysfunction reported in XLAG series and case literature (ffrenchconstant2019fetalandneonatal pages 3-4, okazaki2008aristalessrelatedhomeoboxgene pages 1-2, spinosa2006lissencephalyabnormalgenitalia pages 3-4).

3.2 Quantitative phenotype frequencies (females with heterozygous ARX variants; 2024 synthesis)

A 2024 Journal of Medical Genetics study collated 10 new de novo female cases and reviewed 63 previously reported females. Across females with heterozygous pathogenic ARX variants: 42.5% asymptomatic, 16.4% isolated ACC or mild symptoms, and 41% severe phenotype (ID or DEE) (gras2024furthercharacterisationof pages 1-3). Severe ID/DEE was more prevalent with de novo variants (75%, 15/20) than inherited variants (27.3%, 9/33) (gras2024furthercharacterisationof pages 1-3). Among females undergoing MRI, ACC was observed in 66.7% (24/36) (gras2024furthercharacterisationof pages 1-3).

3.3 Suggested HPO terms (selected)

A phenotype-to-HPO mapping table is provided for knowledge base ingestion: | Phenotype | Typical onset | Notes/frequency (if known) | Suggested HPO ID/label | Key supporting citations | |---|---|---|---|---| | Lissencephaly / pachygyria | Congenital / prenatal | Core feature of XLAG; often posterior-predominant lissencephaly or diffuse pachygyria with relatively mild cortical thickening | HP:0001339 Lissencephaly; HP:0001302 Pachygyria | (drongitis2022deregulationofmicrotubule pages 1-3, ffrenchconstant2019fetalandneonatal pages 3-4) | | Agenesis of the corpus callosum | Congenital / prenatal | Core feature of XLAG; in females with heterozygous ARX variants, ACC seen in 66.7% (24/36) who underwent MRI | HP:0001274 Agenesis of corpus callosum | (gras2024furthercharacterisationof pages 1-3, ffrenchconstant2019fetalandneonatal pages 1-3, gras2024furthercharacterisationof pages 3-4) | | Ambiguous / abnormal male genitalia | Congenital | Defining XLAG feature in affected 46,XY males; includes micropenis, cryptorchidism, hypoplastic external genitalia | HP:0000077 Abnormality of the genitalia; HP:0000054 Ambiguous genitalia; HP:0000046 Cryptorchidism; HP:0000054 Micropenis | (spinosa2006lissencephalyabnormalgenitalia pages 1-3, okazaki2008aristalessrelatedhomeoboxgene pages 1-2, gras2024furthercharacterisationof pages 17-18, ffrenchconstant2019fetalandneonatal pages 4-5) | | Neonatal-onset refractory seizures / epilepsy | Neonatal, often day 1 or within minutes–hours of life | Hallmark of XLAG; usually medically refractory/pharmacoresistant | HP:0002373 Febrile seizures; HP:0001250 Seizures; HP:0012469 Neonatal seizures; HP:0001272 Cerebral visual impairment | (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, ffrenchconstant2019fetalandneonatal pages 3-4, ffrenchconstant2019fetalandneonatal pages 1-3) | | Developmental and epileptic encephalopathy | Neonatal to infancy | Severe ARX spectrum includes Ohtahara/early infantile epileptic encephalopathy and infantile spasms; in de novo ARX females, 6/10 had DEE | HP:0100022 Developmental and epileptic encephalopathy | (eksioglu2011anovelmutation pages 6-7, gras2024furthercharacterisationof pages 3-4, drongitis2022deregulationofmicrotubule pages 1-3, bernardo2024xlinkedepilepsiesa pages 3-4) | | Infantile spasms / West syndrome | Infancy | Common in non-malformative severe ARX disorders and some female cases; part of broader severe ARX epilepsy spectrum | HP:0012469 Infantile spasms | (gras2024furthercharacterisationof pages 17-18, eksioglu2011anovelmutation pages 6-7, gras2024furthercharacterisationof pages 6-7) | | Intellectual disability / global developmental delay | Infancy to childhood recognition | Severe developmental impairment is common; in females with heterozygous pathogenic ARX variants, 41% had severe ID/DEE | HP:0001249 Intellectual disability; HP:0001263 Global developmental delay | (gras2024furthercharacterisationof pages 1-3, eksioglu2011anovelmutation pages 6-7, gras2024furthercharacterisationof pages 3-4, drongitis2022deregulationofmicrotubule pages 1-3) | | Postnatal / acquired microcephaly | Postnatal infancy | Reported in XLAG case series and pathology reports | HP:0000253 Microcephaly; HP:0005484 Postnatal microcephaly | (spinosa2006lissencephalyabnormalgenitalia pages 1-3, okazaki2008aristalessrelatedhomeoboxgene pages 1-2) | | Hypotonia | Neonatal / infancy | Common neurologic sign in severe ARX cases | HP:0001252 Hypotonia | (spinosa2006lissencephalyabnormalgenitalia pages 3-4, gras2024furthercharacterisationof pages 14-15, ffrenchconstant2019fetalandneonatal pages 1-3) | | Spasticity / spastic quadriparesis | Childhood, sometimes progressive | Reported in severe ARX phenotypes including XLAG-related and female severe cases | HP:0001257 Spasticity; HP:0001276 Spastic quadriplegia | (gras2024furthercharacterisationof pages 17-18, gras2024furthercharacterisationof pages 14-15) | | Dystonia / hand dystonia | Childhood | Typical of polyalanine-expansion ARX disorders and Partington-spectrum disease; can coexist with epilepsy/ID | HP:0001332 Dystonia | (drongitis2022deregulationofmicrotubule pages 1-3, dubos2018anewmouse pages 1-2, gras2024furthercharacterisationof pages 6-7) | | Choreoathetoid / dyskinetic movements | Childhood | Reported in severe female ARX cases and broader severe ARX spectrum | HP:0001266 Choreoathetosis; HP:0001300 Abnormality of movement | (gras2024furthercharacterisationof pages 14-15) | | Temperature instability / hypothalamic dysfunction | Neonatal / infancy | Recurrent associated XLAG feature; suggests hypothalamic involvement | HP:0002045 Hypothermia; HP:0012735 Temperature instability | (ffrenchconstant2019fetalandneonatal pages 3-4, okazaki2008aristalessrelatedhomeoboxgene pages 1-2, bernardo2024xlinkedepilepsiesa pages 17-19) | | Chronic diarrhea | Neonatal / infancy | Recurrent extra-neurologic XLAG feature; sometimes responsive to nutritional support | HP:0002014 Diarrhea; HP:0011968 Chronic diarrhea | (spinosa2006lissencephalyabnormalgenitalia pages 3-4, ffrenchconstant2019fetalandneonatal pages 3-4) | | Small basal ganglia / ganglionic eminence abnormalities on MRI | Prenatal / neonatal imaging | Characteristic imaging clue in ARX-related XLAG | HP:0012697 Abnormal basal ganglia MRI signal intensity | (ffrenchconstant2019fetalandneonatal pages 1-3, ffrenchconstant2019fetalandneonatal pages 3-4, ffrenchconstant2019fetalandneonatal media 71a03515) | | Three-layered cortex / interneuron deficit (neuropathology) | Prenatal developmental defect; recognized postmortem/pathology | Histopathologic hallmark supporting the “interneuronopathy” concept | HP:0012443 Abnormal cerebral cortex morphology*** | (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, ffrenchconstant2019fetalandneonatal pages 3-4) | | Autism spectrum disorder / learning difficulties in females | Childhood | In females with pathogenic ARX variants: 16.4% had isolated ACC or mild symptoms such as learning disabilities, ASD, or drug-responsive epilepsy without ID | HP:0000717 Autism; HP:0001328 Learning disability | (gras2024furthercharacterisationof pages 1-3) |

Table: This table maps major neurologic and extra-neurologic features of ARX-related lissencephaly/interneuronopathy and related severe ARX disorders to suggested HPO terms. It is useful for structured disease annotation and phenotype harmonization in a knowledge base.


4. Genetic / molecular information

4.1 Causal gene

ARX encodes an X-linked homeobox transcription factor implicated in interneuron development; ARX variants cause a spectrum from severe malformation syndromes (XLAG) to DEE and ID syndromes without gross malformation (kitamura2009threehumanarx pages 1-2, bernardo2024xlinkedepilepsiesa pages 17-19).

4.2 Variant classes and genotype–phenotype correlations

A consistent genotype–phenotype correlation is repeatedly reported: - XLAG is associated with truncating variants and/or missense variants at critical residues in the homeodomain (gras2024furthercharacterisationof pages 1-3). - Polyalanine expansions (e.g., c.428_451dup24 / Dup24) and missense variants outside the homeodomain are more often associated with infantile spasms/DEE, ID ± dystonia/Partington-spectrum phenotypes without major malformations (gras2024furthercharacterisationof pages 1-3, gras2024furthercharacterisationof pages 6-7, kitamura2009threehumanarx pages 1-2).

A structured table of variant classes and associated phenotypes: | Variant class | Typical molecular effect | Associated clinical entities | Sex effects (males vs females) | Key citations | |---|---|---|---|---| | Truncating variants / exon deletions / null alleles | Severe loss of function; absent or markedly impaired ARX transcriptional activity; loss of homeodomain binding/transcriptional capacity in many cases | Classically associated with the severe malformation spectrum, especially XLAG / ARX-related lissencephaly with agenesis of the corpus callosum and ambiguous genitalia; may also underlie hydranencephaly-abnormal genitalia phenotypes; severe developmental impairment and early lethal epileptic encephalopathy are typical | Hemizygous males are usually severely affected; female carriers often asymptomatic or milder, but de novo female variants can produce severe ID/DEE; variable expression partly attributed to X-inactivation | (gras2024furthercharacterisationof pages 16-17, drongitis2022deregulationofmicrotubule pages 1-3, gras2024furthercharacterisationof pages 1-3, gras2024furthercharacterisationof pages 6-7, kitamura2009threehumanarx pages 1-2) | | Critical homeodomain missense variants | Typically severe loss of function through impaired DNA binding, altered transcriptional capacity, and/or nuclear mislocalization; some HD missense variants are as severe as truncating alleles | XLAG is strongly associated with missense variants at critical homeodomain residues; severe DEE/ID and cortical malformations can also occur | Males usually show severe phenotypes; females may be unaffected, mildly affected, or severely affected if de novo, with variable expressivity | (gras2024furthercharacterisationof pages 16-17, drongitis2022deregulationofmicrotubule pages 1-3, gras2024furthercharacterisationof pages 1-3, gras2024furthercharacterisationof pages 6-7) | | Polyalanine expansions, including c.428_451dup24 (Dup24) | Hypomorphic / partial loss of function; altered transcriptional repression; nuclear mislocalization; aggregation/intranuclear inclusions reported, suggesting an additional toxic gain-of-function component in some models | Usually associated with non-malformative or less-malformative ARX disorders: infantile spasms, DEE1, familial intellectual disability with epilepsy, dystonia/hand dystonia, and Partington-spectrum phenotypes; Dup24 is a recurrent variant in ID/epilepsy/Partington-like disease | Males are typically clinically affected; female relatives are often asymptomatic or mildly affected, though learning difficulties, epilepsy, or ID can occur | (eksioglu2011anovelmutation pages 6-7, drongitis2022deregulationofmicrotubule pages 1-3, gras2024furthercharacterisationof pages 1-3, gras2024furthercharacterisationof pages 6-7, bernardo2024xlinkedepilepsiesa pages 17-19, dubos2018anewmouse pages 1-2) | | Other polyalanine/triplet-repeat insertions, including 33-bp exon 2 duplication | Hypomorphic effect with altered ARX activity; may impair interneuron development and network function; some duplications linked to early epileptic encephalopathy rather than gross malformation | 33-bp exon 2 duplication has been linked to EIEE / Ohtahara syndrome; other polyalanine insertions are associated with epilepsy, learning impairment, and interneuronopathy in mouse models | Reported mainly in affected males; female heterozygotes can show variable neuropsychiatric or cognitive manifestations | (eksioglu2011anovelmutation pages 6-7, kitamura2009threehumanarx pages 1-2) | | Missense variants outside the homeodomain | Often milder functional disturbance than HD variants; may alter repression or cofactor interactions rather than abolish DNA binding | More often associated with intellectual disability with or without dystonia, infantile spasms, and non-syndromic or less-malformative ARX phenotypes rather than classic XLAG | Males generally more consistently affected; females may be unaffected or mildly affected, but penetrance/expressivity are variable | (eksioglu2011anovelmutation pages 6-7, eksioglu2011anovelmutation pages 4-6, gras2024furthercharacterisationof pages 1-3, kitamura2009threehumanarx pages 1-2) |

Table: This table summarizes the main ARX pathogenic variant classes, their usual molecular consequences, and the clinical spectrum they are most strongly associated with. It is useful for quickly linking genotype class to expected severity, malformation risk, and sex-specific expression patterns.

4.3 Functional consequences (current understanding)

  • XLAG-associated ARX loss-of-function variants impair DNA binding/transcriptional capacity and derail interneuron development and migration (ffrenchconstant2019fetalandneonatal pages 3-4, gras2024furthercharacterisationof pages 6-7).
  • Polyalanine expansions can alter repression, mislocalize in nuclei, and form aggregates/inclusions, suggesting hypomorphic and possibly toxic components (eksioglu2011anovelmutation pages 6-7, drongitis2022deregulationofmicrotubule pages 1-3).

5. Environmental information

No XLAG-specific non-genetic environmental contributors were identified in the retrieved evidence.


6. Mechanism / pathophysiology

6.1 Causal chain (from variant to phenotype)

Upstream trigger: Pathogenic ARX variant (often truncating/critical homeodomain missense for XLAG) → loss of ARX transcriptional regulation in ventral telencephalon progenitors and interneuron lineages (ffrenchconstant2019fetalandneonatal pages 3-4, drongitis2022deregulationofmicrotubule pages 1-3).
Cellular consequence: impaired generation, fate specification, and tangential migration of GABAergic interneurons → interneuron deficit/mispositioning (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, ffrenchconstant2019fetalandneonatal pages 3-4).
Circuit consequence: reduced inhibition and abnormal network wiring → neonatal epileptic encephalopathy and severe neurodevelopmental impairment (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, ffrenchconstant2019fetalandneonatal pages 3-4).

6.2 Pathways/processes supported by recent molecular profiling

In ARX mouse and nematode models for XLAG (null) and DEE (polyalanine expansions), omics analyses indicate convergent and allelic-dependent disturbances in: - Microtubule/cytoskeleton regulation: decreased α-tubulin content/acetylation and disorganized neurite networks (secondary tubulinopathy) (drongitis2022deregulationofmicrotubule pages 13-15, drongitis2022deregulationofmicrotubule pages 1-3).
- Translation control: eIF4A2 overexpression and translational suppression (noted in polyalanine expansion model) (drongitis2022deregulationofmicrotubule pages 1-3).
- RNA metabolism / alternative splicing: splicing changes associated with PUF60 and SAM68 and altered Neurexin-1 splicing repertoires, supporting synaptopathy hypotheses (drongitis2022deregulationofmicrotubule pages 13-15, drongitis2022deregulationofmicrotubule pages 1-3).

6.3 Suggested ontology terms

GO Biological Process (suggested): interneuron migration; forebrain development; regulation of transcription; microtubule cytoskeleton organization; RNA splicing; synapse organization.
CL Cell types (suggested): cortical GABAergic interneuron; medial ganglionic eminence (MGE)-derived interneuron progenitor; radial glia; intermediate progenitor cell.
UBERON (suggested): cerebral cortex; corpus callosum; basal ganglia; ganglionic eminence.


7. Anatomical structures affected

Primary: cerebral cortex (lissencephaly/abnormal lamination), corpus callosum (ACC), basal ganglia/ganglionic eminences (often small/abnormal) (ffrenchconstant2019fetalandneonatal pages 3-4).
Systemic/secondary: testes/sex development (ambiguous genitalia), and possible pancreas/GI involvement (chronic diarrhea/pancreatic dysfunction) (ffrenchconstant2019fetalandneonatal pages 3-4, spinosa2006lissencephalyabnormalgenitalia pages 3-4).

Imaging evidence: fetal and neonatal MRI patterns illustrating callosal agenesis, poor sulcation/lissencephaly, and small basal ganglia are shown in retrieved figure crops (ffrenchconstant2019fetalandneonatal media 71a03515, ffrenchconstant2019fetalandneonatal media 71eb2fe9).


8. Temporal development

Onset: Congenital malformation syndrome with neonatal onset seizures, often on day 1 or within hours/minutes (spinosa2006lissencephalyabnormalgenitalia pages 1-3, ffrenchconstant2019fetalandneonatal pages 1-3).
Course: severe developmental impairment; epilepsy typically pharmacoresistant; high infant mortality reported (okazaki2008aristalessrelatedhomeoboxgene pages 1-2, ffrenchconstant2019fetalandneonatal pages 3-4).


9. Inheritance and population

9.1 Inheritance

Predominantly X-linked; males typically severely affected; females can range from asymptomatic to severe DEE/ID, influenced in part by X-chromosome inactivation (bernardo2024xlinkedepilepsiesa pages 17-19, gras2024furthercharacterisationof pages 15-15).

9.2 Epidemiology

No robust prevalence/incidence estimates were present in the retrieved evidence set; XLAG is consistently described as rare.


10. Diagnostics

10.1 Imaging

Prenatal clues: fetal ultrasound and fetal MRI can detect absent midline structures/callosal agenesis and poor sulcation; fetal MRI example at 26 weeks shows characteristic features (ffrenchconstant2019fetalandneonatal pages 1-3, ffrenchconstant2019fetalandneonatal media 71a03515).
Neonatal MRI: microlissencephaly/lissencephaly, ACC, and small/indistinct basal ganglia are characteristic (ffrenchconstant2019fetalandneonatal pages 1-3, ffrenchconstant2019fetalandneonatal media 71eb2fe9).

10.2 EEG / electrophysiology

In XLAG, EEG abnormalities include disorganized background and electroclinical/electrographic seizures; some summaries report hypsarrhythmia/multifocal epileptiform activity in ARX-related epilepsies more broadly (spinosa2006lissencephalyabnormalgenitalia pages 3-4, bernardo2024xlinkedepilepsiesa pages 3-4).

10.3 Genetic testing approaches (real-world implementation)

In de novo female ARX cohorts, diagnostic workflows included gene panels (6/10), WES (2/10), WGS (1/10), and targeted sequencing (1/10) with Sanger confirmation and parental testing (gras2024furthercharacterisationof pages 3-4). In XLAG-like presentations, imaging patterns may guide targeted ARX testing (ffrenchconstant2019fetalandneonatal pages 1-3).

10.4 Differential diagnosis (high-level)

Within the malformations-of-cortical-development differential: other neuronal migration disorders (e.g., DCX-related lissencephaly) and tubulinopathies can resemble aspects of ARX-associated malformations; ARX is explicitly discussed among X-linked neuronal migration disorder genes in contemporary review literature (bernardo2024xlinkedepilepsiesa pages 17-19).


11. Outcome / prognosis

Prognosis in classic XLAG is poor. Multiple sources describe early mortality, with statements such as “Most XLAG patients die within 1 year after birth” (okazaki2008aristalessrelatedhomeoboxgene pages 1-2) and an average survival ~18 months with maximum reported 4 years (ffrenchconstant2019fetalandneonatal pages 3-4, spinosa2006lissencephalyabnormalgenitalia pages 3-4).


12. Treatment

12.1 Anti-seizure medications (ASMs) and pharmacoresistance

Neonatal seizures are often pharmacoresistant. In one neonatal XLAG case, seizures persisted despite phenobarbitone, phenytoin, and levetiracetam (ffrenchconstant2019fetalandneonatal pages 1-3). A female ARX cohort defined drug-resistant epilepsy as failure of ≥2 ASMs or vagus nerve stimulation (VNS) and reported pharmacoresistance in 4/10 de novo female cases (gras2024furthercharacterisationof pages 3-4).

12.2 Supportive care

Supportive GI/nutritional management may be required; a case report notes chronic diarrhea that responded to a semi-elementary formula (spinosa2006lissencephalyabnormalgenitalia pages 3-4).

12.3 Advanced therapeutics / experimental

No interventional gene therapy or ARX-targeted clinical trials were identified in the retrieved evidence set.

MAXO (suggested): antiseizure therapy; genetic testing; prenatal imaging; vagus nerve stimulation; nutritional support.


13. Prevention

Primary prevention is not currently available for de novo cases. Secondary prevention centers on prenatal diagnosis (ultrasound/fetal MRI), early genetic confirmation, and genetic counseling for at-risk families (ffrenchconstant2019fetalandneonatal pages 1-3, ffrenchconstant2019fetalandneonatal pages 4-5).


14. Other species / natural disease

No naturally occurring ARX/XLAG-like disease in non-human species was identified in the retrieved evidence.


15. Model organisms and experimental systems

Multiple experimental systems recapitulate ARX endophenotypes: - Mouse Arx knockout (XLAG model) and polyalanine expansion knock-in mice (DEE models) with interneuron deficits, seizures, and allele-specific molecular signatures (drongitis2022deregulationofmicrotubule pages 1-3, kitamura2009threehumanarx pages 1-2).
- Arxdup24 knock-in mouse modeling recurrent Dup24 variant with interneuron-gene dysregulation, migration defects, E/I imbalance, and behavioral/fine motor phenotypes (dubos2018anewmouse pages 1-2).
- C. elegans alr-1 knockout (ARX orthologue) showing conserved cytoskeletal and GABAergic maturation phenotypes (drongitis2022deregulationofmicrotubule pages 1-3).
- Human iPSC-derived cortical organoids, ganglionic eminence organoids, and assembloids with ARX polyalanine expansion variants: altered progenitor trajectories, accelerated interneuron migration linked to CXCR4/CXCL12 axis, and network hyperactivity, with migration rescue by CXCR4 inhibition (nietoestevez2024dualeffectsof pages 4-7).


Current applications / real-world implementations (registries)

Simons Searchlight (ClinicalTrials.gov NCT01238250; observational registry): A large, remote, family-based, international program collecting longitudinal medical/developmental/behavioral data and biospecimens. ARX is explicitly listed among eligible genetic conditions; data are de-identified and shared with qualified researchers (NCT01238250 chunk 1).


Recent developments (prioritizing 2023–2024)

  1. Female phenotypic delineation and quantitative frequencies (2024): A 2024 Journal of Medical Genetics study synthesized 73 females and provided frequency estimates for asymptomatic vs mild ACC vs severe ID/DEE, with de novo variants showing substantially higher severe-phenotype rates (gras2024furthercharacterisationof pages 1-3).
  2. Updated expert synthesis of ARX among X-linked epilepsies (2024): A 2024 narrative review emphasizes ARX’s role in interneuron migration/differentiation and highlights that female phenotypes can be attenuated/variable due to X-inactivation (bernardo2024xlinkedepilepsiesa pages 17-19).
  3. Human stem-cell organoid modeling of ARX polyalanine expansions (2024 preprint): Human cortical and ganglionic eminence organoids/assembloids identify cell-type- and developmental-stage-dependent effects on progenitors, interneuron migration, and network activity, supporting translational platforms for pathway-guided interventions (nietoestevez2024dualeffectsof pages 4-7).

Expert opinions / analysis (authoritative sources)

  • Pathology-based analyses support that XLAG involves profound disruption of interneuron development/migration and severe cortical malformation with early lethal epileptic encephalopathy (okazaki2008aristalessrelatedhomeoboxgene pages 1-2).
  • Contemporary reviews frame ARX disorders as a continuum of X-linked epilepsies and neuronal migration disorders and highlight the complicating role of X-inactivation in females for genotype–phenotype correlation and counseling (bernardo2024xlinkedepilepsiesa pages 17-19).

Evidence excerpts (direct abstract quotes)

  • Okazaki et al., 2008 (Acta Neuropathologica; DOI: https://doi.org/10.1007/s00401-008-0382-2; May 2008): “X-linked lissencephaly with abnormal genitalia (XLAG) is a rare disorder caused by mutations in the aristaless-related homeobox (ARX) gene …” (okazaki2008aristalessrelatedhomeoboxgene pages 1-2).
  • Spinosa et al., 2006 (Arq Neuropsiquiatr; DOI: https://doi.org/10.1590/s0004-282x2006000600027; Dec 2006): “Patients present with lissencephaly, agenesis of the corpus callosum, refractory epilepsy of neonatal onset, acquired microcephaly and male genotype with ambiguous genitalia.” (spinosa2006lissencephalyabnormalgenitalia pages 3-4).
  • Gras et al., 2024 (J Med Genet; DOI: https://doi.org/10.1136/jmg-2023-109203; Oct 2024): “Altogether, the clinical spectrum of females with heterozygous pathogenic ARX variants is broad: 42.5% are asymptomatic…” (gras2024furthercharacterisationof pages 1-3).

Limitations and gaps

  • Formal mappings to MONDO/Orphanet/ICD/MeSH were not retrievable with the current tool evidence set; OMIM-based mapping is recommended as a next step.
  • Robust epidemiology (prevalence/incidence) and validated treatment guidelines specific to XLAG were not present in the retrieved evidence.

References

  1. (okazaki2008aristalessrelatedhomeoboxgene pages 1-2): Shin Okazaki, Maki Ohsawa, Ichiro Kuki, Hisashi Kawawaki, Takeshi Koriyama, Shingou Ri, Hiroyuki Ichiba, Eishu Hai, Takeshi Inoue, Hiroaki Nakamura, Yu-ichi Goto, Kiyotaka Tomiwa, Tsunekazu Yamano, Kunio Kitamura, and Masayuki Itoh. Aristaless-related homeobox gene disruption leads to abnormal distribution of gabaergic interneurons in human neocortex: evidence based on a case of x-linked lissencephaly with abnormal genitalia (xlag). Acta Neuropathologica, 116:453-462, May 2008. URL: https://doi.org/10.1007/s00401-008-0382-2, doi:10.1007/s00401-008-0382-2. This article has 66 citations and is from a highest quality peer-reviewed journal.

  2. (drongitis2022deregulationofmicrotubule pages 1-3): Denise Drongitis, Marianna Caterino, Lucia Verrillo, Pamela Santonicola, Michele Costanzo, Loredana Poeta, Benedetta Attianese, Adriano Barra, Gaetano Terrone, Maria Brigida Lioi, Simona Paladino, Elia Di Schiavi, Valerio Costa, Margherita Ruoppolo, and Maria Giuseppina Miano. Deregulation of microtubule organization and rna metabolism in arx models for lissencephaly and developmental epileptic encephalopathy. Human Molecular Genetics, 31:1884-1908, Jan 2022. URL: https://doi.org/10.1093/hmg/ddac028, doi:10.1093/hmg/ddac028. This article has 13 citations and is from a domain leading peer-reviewed journal.

  3. (eksioglu2011anovelmutation pages 6-7): Yaman Z. Ekşioğlu, Amanda W. Pong, and Masanori Takeoka. A novel mutation in the aristaless domain of the arx gene leads to ohtahara syndrome, global developmental delay, and ambiguous genitalia in males and neuropsychiatric disorders in females. Epilepsia, May 2011. URL: https://doi.org/10.1111/j.1528-1167.2011.02980.x, doi:10.1111/j.1528-1167.2011.02980.x. This article has 42 citations and is from a domain leading peer-reviewed journal.

  4. (bernardo2024xlinkedepilepsiesa pages 17-19): Pia Bernardo, Claudia Cuccurullo, Marica Rubino, Gabriella De Vita, Gaetano Terrone, Leonilda Bilo, and Antonietta Coppola. X-linked epilepsies: a narrative review. International Journal of Molecular Sciences, 25:4110, Apr 2024. URL: https://doi.org/10.3390/ijms25074110, doi:10.3390/ijms25074110. This article has 14 citations.

  5. (spinosa2006lissencephalyabnormalgenitalia pages 1-3): Mônica Jaques Spinosa, Paulo Breno Noronha Liberalesso, Simone Carreiro Vieira, Alaídes Susana Fojo Olmos, and Alfredo Löhr Júnior. Lissencephaly, abnormal genitalia and refractory epilepsy: case report of xlag syndrome. Arquivos de neuro-psiquiatria, 64 4:1023-6, Dec 2006. URL: https://doi.org/10.1590/s0004-282x2006000600027, doi:10.1590/s0004-282x2006000600027. This article has 19 citations and is from a peer-reviewed journal.

  6. (ffrenchconstant2019fetalandneonatal pages 3-4): Sara ffrench-Constant, Carolina Kachramanoglou, Brynmor Jones, Nigel Basheer, Nikolaos Syrmos, Mario Ganau, and Wajanat Jan. Fetal and neonatal mri features of arx-related lissencephaly presenting with neonatal refractory seizure disorder. Quantitative Imaging in Medicine and Surgery, 9:1767-1772, Nov 2019. URL: https://doi.org/10.21037/qims.2019.10.14, doi:10.21037/qims.2019.10.14. This article has 8 citations and is from a peer-reviewed journal.

  7. (bernardo2024xlinkedepilepsiesa pages 3-4): Pia Bernardo, Claudia Cuccurullo, Marica Rubino, Gabriella De Vita, Gaetano Terrone, Leonilda Bilo, and Antonietta Coppola. X-linked epilepsies: a narrative review. International Journal of Molecular Sciences, 25:4110, Apr 2024. URL: https://doi.org/10.3390/ijms25074110, doi:10.3390/ijms25074110. This article has 14 citations.

  8. (gras2024furthercharacterisationof pages 1-3): Mathilde Gras, Solveig Heide, Boris Keren, Stéphanie Valence, Catherine Garel, Sandra Whalen, Anna C Jansen, Kathelijn Keymolen, Katrien Stouffs, Mélanie Jennesson, Céline Poirsier, Gaetan Lesca, Christel Depienne, Caroline Nava, Agnès Rastetter, Aurore Curie, Laurence Cuisset, Vincent Des Portes, Mathieu Milh, Perrine Charles, Cyril Mignot, and Delphine Héron. Further characterisation of arx-related disorders in females due to inherited or de novo variants. Journal of Medical Genetics, 61:103-108, Oct 2024. URL: https://doi.org/10.1136/jmg-2023-109203, doi:10.1136/jmg-2023-109203. This article has 7 citations and is from a domain leading peer-reviewed journal.

  9. (ffrenchconstant2019fetalandneonatal pages 1-3): Sara ffrench-Constant, Carolina Kachramanoglou, Brynmor Jones, Nigel Basheer, Nikolaos Syrmos, Mario Ganau, and Wajanat Jan. Fetal and neonatal mri features of arx-related lissencephaly presenting with neonatal refractory seizure disorder. Quantitative Imaging in Medicine and Surgery, 9:1767-1772, Nov 2019. URL: https://doi.org/10.21037/qims.2019.10.14, doi:10.21037/qims.2019.10.14. This article has 8 citations and is from a peer-reviewed journal.

  10. (gras2024furthercharacterisationof pages 15-15): Mathilde Gras, Solveig Heide, Boris Keren, Stéphanie Valence, Catherine Garel, Sandra Whalen, Anna C Jansen, Kathelijn Keymolen, Katrien Stouffs, Mélanie Jennesson, Céline Poirsier, Gaetan Lesca, Christel Depienne, Caroline Nava, Agnès Rastetter, Aurore Curie, Laurence Cuisset, Vincent Des Portes, Mathieu Milh, Perrine Charles, Cyril Mignot, and Delphine Héron. Further characterisation of arx-related disorders in females due to inherited or de novo variants. Journal of Medical Genetics, 61:103-108, Oct 2024. URL: https://doi.org/10.1136/jmg-2023-109203, doi:10.1136/jmg-2023-109203. This article has 7 citations and is from a domain leading peer-reviewed journal.

  11. (spinosa2006lissencephalyabnormalgenitalia pages 3-4): Mônica Jaques Spinosa, Paulo Breno Noronha Liberalesso, Simone Carreiro Vieira, Alaídes Susana Fojo Olmos, and Alfredo Löhr Júnior. Lissencephaly, abnormal genitalia and refractory epilepsy: case report of xlag syndrome. Arquivos de neuro-psiquiatria, 64 4:1023-6, Dec 2006. URL: https://doi.org/10.1590/s0004-282x2006000600027, doi:10.1590/s0004-282x2006000600027. This article has 19 citations and is from a peer-reviewed journal.

  12. (gras2024furthercharacterisationof pages 3-4): Mathilde Gras, Solveig Heide, Boris Keren, Stéphanie Valence, Catherine Garel, Sandra Whalen, Anna C Jansen, Kathelijn Keymolen, Katrien Stouffs, Mélanie Jennesson, Céline Poirsier, Gaetan Lesca, Christel Depienne, Caroline Nava, Agnès Rastetter, Aurore Curie, Laurence Cuisset, Vincent Des Portes, Mathieu Milh, Perrine Charles, Cyril Mignot, and Delphine Héron. Further characterisation of arx-related disorders in females due to inherited or de novo variants. Journal of Medical Genetics, 61:103-108, Oct 2024. URL: https://doi.org/10.1136/jmg-2023-109203, doi:10.1136/jmg-2023-109203. This article has 7 citations and is from a domain leading peer-reviewed journal.

  13. (gras2024furthercharacterisationof pages 17-18): Mathilde Gras, Solveig Heide, Boris Keren, Stéphanie Valence, Catherine Garel, Sandra Whalen, Anna C Jansen, Kathelijn Keymolen, Katrien Stouffs, Mélanie Jennesson, Céline Poirsier, Gaetan Lesca, Christel Depienne, Caroline Nava, Agnès Rastetter, Aurore Curie, Laurence Cuisset, Vincent Des Portes, Mathieu Milh, Perrine Charles, Cyril Mignot, and Delphine Héron. Further characterisation of arx-related disorders in females due to inherited or de novo variants. Journal of Medical Genetics, 61:103-108, Oct 2024. URL: https://doi.org/10.1136/jmg-2023-109203, doi:10.1136/jmg-2023-109203. This article has 7 citations and is from a domain leading peer-reviewed journal.

  14. (ffrenchconstant2019fetalandneonatal pages 4-5): Sara ffrench-Constant, Carolina Kachramanoglou, Brynmor Jones, Nigel Basheer, Nikolaos Syrmos, Mario Ganau, and Wajanat Jan. Fetal and neonatal mri features of arx-related lissencephaly presenting with neonatal refractory seizure disorder. Quantitative Imaging in Medicine and Surgery, 9:1767-1772, Nov 2019. URL: https://doi.org/10.21037/qims.2019.10.14, doi:10.21037/qims.2019.10.14. This article has 8 citations and is from a peer-reviewed journal.

  15. (gras2024furthercharacterisationof pages 6-7): Mathilde Gras, Solveig Heide, Boris Keren, Stéphanie Valence, Catherine Garel, Sandra Whalen, Anna C Jansen, Kathelijn Keymolen, Katrien Stouffs, Mélanie Jennesson, Céline Poirsier, Gaetan Lesca, Christel Depienne, Caroline Nava, Agnès Rastetter, Aurore Curie, Laurence Cuisset, Vincent Des Portes, Mathieu Milh, Perrine Charles, Cyril Mignot, and Delphine Héron. Further characterisation of arx-related disorders in females due to inherited or de novo variants. Journal of Medical Genetics, 61:103-108, Oct 2024. URL: https://doi.org/10.1136/jmg-2023-109203, doi:10.1136/jmg-2023-109203. This article has 7 citations and is from a domain leading peer-reviewed journal.

  16. (gras2024furthercharacterisationof pages 14-15): Mathilde Gras, Solveig Heide, Boris Keren, Stéphanie Valence, Catherine Garel, Sandra Whalen, Anna C Jansen, Kathelijn Keymolen, Katrien Stouffs, Mélanie Jennesson, Céline Poirsier, Gaetan Lesca, Christel Depienne, Caroline Nava, Agnès Rastetter, Aurore Curie, Laurence Cuisset, Vincent Des Portes, Mathieu Milh, Perrine Charles, Cyril Mignot, and Delphine Héron. Further characterisation of arx-related disorders in females due to inherited or de novo variants. Journal of Medical Genetics, 61:103-108, Oct 2024. URL: https://doi.org/10.1136/jmg-2023-109203, doi:10.1136/jmg-2023-109203. This article has 7 citations and is from a domain leading peer-reviewed journal.

  17. (dubos2018anewmouse pages 1-2): Aline Dubos, Hamid Meziane, Giovanni Iacono, Aurore Curie, Fabrice Riet, Christelle Martin, Nadège Loaëc, Marie-Christine Birling, Mohammed Selloum, Elisabeth Normand, Guillaume Pavlovic, Tania Sorg, Henk G Stunnenberg, Jamel Chelly, Yann Humeau, Gaëlle Friocourt, and Yann Hérault. A new mouse model of arx dup24 recapitulates the patients’ behavioral and fine motor alterations. Human Molecular Genetics, 27:2138-2153, Apr 2018. URL: https://doi.org/10.1093/hmg/ddy122, doi:10.1093/hmg/ddy122. This article has 28 citations and is from a domain leading peer-reviewed journal.

  18. (ffrenchconstant2019fetalandneonatal media 71a03515): Sara ffrench-Constant, Carolina Kachramanoglou, Brynmor Jones, Nigel Basheer, Nikolaos Syrmos, Mario Ganau, and Wajanat Jan. Fetal and neonatal mri features of arx-related lissencephaly presenting with neonatal refractory seizure disorder. Quantitative Imaging in Medicine and Surgery, 9:1767-1772, Nov 2019. URL: https://doi.org/10.21037/qims.2019.10.14, doi:10.21037/qims.2019.10.14. This article has 8 citations and is from a peer-reviewed journal.

  19. (kitamura2009threehumanarx pages 1-2): Kunio Kitamura, Yukiko Itou, Masako Yanazawa, Maki Ohsawa, Rika Suzuki-Migishima, Yuko Umeki, Hirohiko Hohjoh, Yuchio Yanagawa, Toshikazu Shinba, Masayuki Itoh, Kenji Nakamura, and Yu-ichi Goto. Three human arx mutations cause the lissencephaly-like and mental retardation with epilepsy-like pleiotropic phenotypes in mice. Human molecular genetics, 18 19:3708-24, Oct 2009. URL: https://doi.org/10.1093/hmg/ddp318, doi:10.1093/hmg/ddp318. This article has 102 citations and is from a domain leading peer-reviewed journal.

  20. (gras2024furthercharacterisationof pages 16-17): Mathilde Gras, Solveig Heide, Boris Keren, Stéphanie Valence, Catherine Garel, Sandra Whalen, Anna C Jansen, Kathelijn Keymolen, Katrien Stouffs, Mélanie Jennesson, Céline Poirsier, Gaetan Lesca, Christel Depienne, Caroline Nava, Agnès Rastetter, Aurore Curie, Laurence Cuisset, Vincent Des Portes, Mathieu Milh, Perrine Charles, Cyril Mignot, and Delphine Héron. Further characterisation of arx-related disorders in females due to inherited or de novo variants. Journal of Medical Genetics, 61:103-108, Oct 2024. URL: https://doi.org/10.1136/jmg-2023-109203, doi:10.1136/jmg-2023-109203. This article has 7 citations and is from a domain leading peer-reviewed journal.

  21. (eksioglu2011anovelmutation pages 4-6): Yaman Z. Ekşioğlu, Amanda W. Pong, and Masanori Takeoka. A novel mutation in the aristaless domain of the arx gene leads to ohtahara syndrome, global developmental delay, and ambiguous genitalia in males and neuropsychiatric disorders in females. Epilepsia, May 2011. URL: https://doi.org/10.1111/j.1528-1167.2011.02980.x, doi:10.1111/j.1528-1167.2011.02980.x. This article has 42 citations and is from a domain leading peer-reviewed journal.

  22. (drongitis2022deregulationofmicrotubule pages 13-15): Denise Drongitis, Marianna Caterino, Lucia Verrillo, Pamela Santonicola, Michele Costanzo, Loredana Poeta, Benedetta Attianese, Adriano Barra, Gaetano Terrone, Maria Brigida Lioi, Simona Paladino, Elia Di Schiavi, Valerio Costa, Margherita Ruoppolo, and Maria Giuseppina Miano. Deregulation of microtubule organization and rna metabolism in arx models for lissencephaly and developmental epileptic encephalopathy. Human Molecular Genetics, 31:1884-1908, Jan 2022. URL: https://doi.org/10.1093/hmg/ddac028, doi:10.1093/hmg/ddac028. This article has 13 citations and is from a domain leading peer-reviewed journal.

  23. (ffrenchconstant2019fetalandneonatal media 71eb2fe9): Sara ffrench-Constant, Carolina Kachramanoglou, Brynmor Jones, Nigel Basheer, Nikolaos Syrmos, Mario Ganau, and Wajanat Jan. Fetal and neonatal mri features of arx-related lissencephaly presenting with neonatal refractory seizure disorder. Quantitative Imaging in Medicine and Surgery, 9:1767-1772, Nov 2019. URL: https://doi.org/10.21037/qims.2019.10.14, doi:10.21037/qims.2019.10.14. This article has 8 citations and is from a peer-reviewed journal.

  24. (nietoestevez2024dualeffectsof pages 4-7): Vanesa Nieto-Estevez, Parul Varma, Sara Mirsadeghi, Jimena Caballero, Sergio Gamero-Alameda, Ali Hosseini, Marc J. Silvosa, Drew M. Thodeson, Zane R. Lybrand, Michele Giugliano, Christopher Navara, and Jenny Hsieh. Dual effects of arx poly-alanine mutations in human cortical and interneuron development. bioRxiv, Jan 2024. URL: https://doi.org/10.1101/2024.01.25.577271, doi:10.1101/2024.01.25.577271. This article has 5 citations.

  25. (NCT01238250 chunk 1): Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight. Simons Searchlight. 2010. ClinicalTrials.gov Identifier: NCT01238250

Artifacts